<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/nport" xmlns:com="http://www.sec.gov/edgar/common" xmlns:ncom="http://www.sec.gov/edgar/nportcommon" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sec.gov/edgar/nport eis_NPORT_Filer.xsd">
  <headerData>
    <submissionType>NPORT-P</submissionType>
    <isConfidential>false</isConfidential>
    <filerInfo>

      <filer>
        <issuerCredentials>
          <cik>0001378872</cik>
          <ccc>XXXXXXXX</ccc>
        </issuerCredentials>
      </filer>


      <seriesClassInfo>
        <seriesId>S000072469</seriesId>
        <classId>C000228754</classId>
      </seriesClassInfo>


    </filerInfo>
  </headerData>
  <formData>
    <genInfo>
      <regName>Invesco Exchange-Traded Fund Trust II</regName>
      <regFileNumber>811-21977</regFileNumber>
      <regCik>0001378872</regCik>
      <regLei>O540V2L4S174Y60FMD36</regLei>
      <regStreet1>3500 Lacey Road</regStreet1>
      <regStreet2>Suite 700</regStreet2>
      <regCity>Downers Grove</regCity>
      <regStateConditional regCountry="US" regState="US-IL"/>
      <regZipOrPostalCode>60515</regZipOrPostalCode>
      <regPhone>800-983-0903</regPhone>
      <seriesName>Invesco Nasdaq Biotechnology ETF</seriesName>
      <seriesId>S000072469</seriesId>
      <seriesLei>549300GYFD12WC2CZH57</seriesLei>
      <repPdEnd>2022-08-31</repPdEnd>
      <repPdDate>2022-08-31</repPdDate>
      <isFinalFiling>N</isFinalFiling>
    </genInfo>
    <fundInfo>
      <totAssets>23048379.81</totAssets>
      <totLiabs>2694754.68</totLiabs>
      <netAssets>20353625.13</netAssets>
      <assetsAttrMiscSec>0.00000000</assetsAttrMiscSec>
      <assetsInvested>0.00000000</assetsInvested>
      <amtPayOneYrBanksBorr>0.00000000</amtPayOneYrBanksBorr>
      <amtPayOneYrCtrldComp>0.00000000</amtPayOneYrCtrldComp>
      <amtPayOneYrOthAffil>0.00000000</amtPayOneYrOthAffil>
      <amtPayOneYrOther>0.00000000</amtPayOneYrOther>
      <amtPayAftOneYrBanksBorr>0.00000000</amtPayAftOneYrBanksBorr>
      <amtPayAftOneYrCtrldComp>0.00000000</amtPayAftOneYrCtrldComp>
      <amtPayAftOneYrOthAffil>0.00000000</amtPayAftOneYrOthAffil>
      <amtPayAftOneYrOther>0.00000000</amtPayAftOneYrOther>
      <delayDeliv>0.00000000</delayDeliv>
      <standByCommit>0.00000000</standByCommit>
      <liquidPref>0.00000000</liquidPref>
      <cshNotRptdInCorD>0.00000000</cshNotRptdInCorD>
      <borrowers>
        <borrower aggrVal="21961.70000000" lei="KB1H1DSPRFMYMCUFXT09" name="WELLS FARGO BANK NA"/>
        <borrower aggrVal="7863.59000000" lei="549300BLWPABP1VNME36" name="Scotia Capital (USA) INC"/>
        <borrower aggrVal="364137.27000000" lei="9R7GPTSO7KV3UQJZQ078" name="Morgan Stanley &amp; Co. LLC"/>
        <borrower aggrVal="1654.40000000" lei="RUC0QBLBRPRCU4W1NE59" name="BMO Capital Markets Corp"/>
        <borrower aggrVal="9391.98000000" lei="ZI8Q1A8EI8LQFJNM0D94" name="Pershing LLC"/>
        <borrower aggrVal="430675.67000000" lei="BFM8T61CT2L1QCEMIK50" name="UBS AG"/>
        <borrower aggrVal="61310.18000000" lei="58PU97L1C0WSRCWADL48" name="Jefferies LLC"/>
        <borrower aggrVal="561578.37000000" lei="ZBUT11V806EZRVTWT807" name="J.P. Morgan Securities LLC"/>
        <borrower aggrVal="78176.89000000" lei="549300ZBQI1JB1844X09" name="TD PRIME SERVICES LLC"/>
        <borrower aggrVal="278702.68000000" lei="MBNUM2BPBDO7JBLYG310" name="Citigroup Global Markets Inc."/>
        <borrower aggrVal="633130.65000000" lei="549300HN4UKV1E2R3U73" name="BOFA SECURITIES INC"/>
        <borrower aggrVal="173431.59000000" lei="VYVVCKR63DVZZN70PB21" name="Wells Fargo Securities LLC"/>
      </borrowers>
      <isNonCashCollateral>N</isNonCashCollateral>
      <returnInfo>
        <monthlyTotReturns>
          <monthlyTotReturn classId="C000228754" rtn1="1.09700000" rtn2="4.09478700" rtn3="-0.97013800"/>
        </monthlyTotReturns>
        <monthlyReturnCats>
          <commodityContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </commodityContracts>
          <creditContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </creditContracts>
          <equityContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </equityContracts>
          <foreignExchgContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </foreignExchgContracts>
          <interestRtContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </interestRtContracts>
          <otherContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </otherContracts>
        </monthlyReturnCats>
        <othMon1 netRealizedGain="-782291.33000000" netUnrealizedAppr="1037355.57000000"/>
        <othMon2 netRealizedGain="-22202.42000000" netUnrealizedAppr="863131.31000000"/>
        <othMon3 netRealizedGain="171384.99000000" netUnrealizedAppr="-378738.77000000"/>
      </returnInfo>
      <mon1Flow redemption="8147195.41000000" reinvestment="0.00000000" sales="4927056.53000000"/>
      <mon2Flow redemption="0.00000000" reinvestment="0.00000000" sales="792465.61000000"/>
      <mon3Flow redemption="2189527.41000000" reinvestment="0.00000000" sales="414942.60000000"/>

    </fundInfo>
    <invstOrSecs>
      <invstOrSec>
        <name>Applied Therapeutics, Inc.</name>
        <lei>549300KL3IJPHZM2GR04</lei>
        <title>Applied Therapeutics, Inc.</title>
        <cusip>03828A101</cusip>
        <identifiers>
          <isin value="US03828A1016"/>
        </identifiers>
        <balance>988.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1353.56000000</valUSD>
        <pctVal>0.006650215828</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MannKind Corp.</name>
        <lei>213800GFBCNY1ZFST722</lei>
        <title>MannKind Corp.</title>
        <cusip>56400P706</cusip>
        <identifiers>
          <isin value="US56400P7069"/>
        </identifiers>
        <balance>5290.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>19308.50000000</valUSD>
        <pctVal>0.094865164690</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="921.06000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Vor BioPharma Inc.</name>
        <lei>N/A</lei>
        <title>Vor BioPharma Inc.</title>
        <cusip>929033108</cusip>
        <identifiers>
          <isin value="US9290331084"/>
        </identifiers>
        <balance>796.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4083.48000000</valUSD>
        <pctVal>0.020062666841</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3845.44000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>NextCure, Inc.</name>
        <lei>549300Y5PR6RJR1STI24</lei>
        <title>NextCure, Inc.</title>
        <cusip>65343E108</cusip>
        <identifiers>
          <isin value="US65343E1082"/>
        </identifiers>
        <balance>596.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2443.60000000</valUSD>
        <pctVal>0.012005723719</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Bicycle Therapeutics PLC</name>
        <lei>213800XKUI6R7GKC3E43</lei>
        <title>Bicycle Therapeutics PLC, ADR</title>
        <cusip>088786108</cusip>
        <identifiers>
          <isin value="US0887861088"/>
        </identifiers>
        <balance>534.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14124.30000000</valUSD>
        <pctVal>0.069394517732</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Passage Bio, Inc.</name>
        <lei>N/A</lei>
        <title>Passage Bio, Inc.</title>
        <cusip>702712100</cusip>
        <identifiers>
          <isin value="US7027121000"/>
        </identifiers>
        <balance>1134.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2290.68000000</valUSD>
        <pctVal>0.011254407926</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Athira Pharma, Inc.</name>
        <lei>N/A</lei>
        <title>Athira Pharma, Inc.</title>
        <cusip>04746L104</cusip>
        <identifiers>
          <isin value="US04746L1044"/>
        </identifiers>
        <balance>760.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2568.80000000</valUSD>
        <pctVal>0.012620847557</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ionis Pharmaceuticals, Inc.</name>
        <lei>549300SI4ZGLG0BLUZ92</lei>
        <title>Ionis Pharmaceuticals, Inc.</title>
        <cusip>462222100</cusip>
        <identifiers>
          <isin value="US4622221004"/>
        </identifiers>
        <balance>2982.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>126794.64000000</valUSD>
        <pctVal>0.622958510782</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="123482.16000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Molecular Templates, Inc.</name>
        <lei>529900VZKP6N0B8U5F61</lei>
        <title>Molecular Templates, Inc.</title>
        <cusip>608550109</cusip>
        <identifiers>
          <isin value="US6085501095"/>
        </identifiers>
        <balance>1182.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>867.23000000</valUSD>
        <pctVal>0.004260813464</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>United Therapeutics Corp.</name>
        <lei>5299005C4HZL4UWROC14</lei>
        <title>United Therapeutics Corp.</title>
        <cusip>91307C102</cusip>
        <identifiers>
          <isin value="US91307C1027"/>
        </identifiers>
        <balance>951.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>215515.62000000</valUSD>
        <pctVal>1.058856192071</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>uniQure N.V.</name>
        <lei>724500RPCTZLFYJZ3S98</lei>
        <title>uniQure N.V.</title>
        <cusip>N90064101</cusip>
        <identifiers>
          <isin value="NL0010696654"/>
        </identifiers>
        <balance>980.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>19149.20000000</valUSD>
        <pctVal>0.094082503129</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Prometheus Biosciences, Inc.</name>
        <lei>N/A</lei>
        <title>Prometheus Biosciences, Inc.</title>
        <cusip>74349U108</cusip>
        <identifiers>
          <isin value="US74349U1088"/>
        </identifiers>
        <balance>818.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>42789.58000000</valUSD>
        <pctVal>0.210230756077</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ORIC Pharmaceuticals, Inc.</name>
        <lei>54930033FJRNEYBW0L25</lei>
        <title>ORIC Pharmaceuticals, Inc.</title>
        <cusip>68622P109</cusip>
        <identifiers>
          <isin value="US68622P1093"/>
        </identifiers>
        <balance>824.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2851.04000000</valUSD>
        <pctVal>0.014007529281</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Akouos, Inc.</name>
        <lei>N/A</lei>
        <title>Akouos, Inc.</title>
        <cusip>00973J101</cusip>
        <identifiers>
          <isin value="US00973J1016"/>
        </identifiers>
        <balance>723.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2422.05000000</valUSD>
        <pctVal>0.011899845774</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Madrigal Pharmaceuticals, Inc.</name>
        <lei>549300CHIMT2EUSNJB60</lei>
        <title>Madrigal Pharmaceuticals, Inc.</title>
        <cusip>558868105</cusip>
        <identifiers>
          <isin value="US5588681057"/>
        </identifiers>
        <balance>363.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>26179.56000000</valUSD>
        <pctVal>0.128623573603</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="23474.64000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>4D Molecular Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>4D Molecular Therapeutics, Inc.</title>
        <cusip>35104E100</cusip>
        <identifiers>
          <isin value="US35104E1001"/>
        </identifiers>
        <balance>679.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5336.94000000</valUSD>
        <pctVal>0.026221078387</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Aligos Therapeutics, Inc.</name>
        <lei>549300UU2UJIKJYX0S67</lei>
        <title>Aligos Therapeutics, Inc.</title>
        <cusip>01626L105</cusip>
        <identifiers>
          <isin value="US01626L1052"/>
        </identifiers>
        <balance>827.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1033.75000000</valUSD>
        <pctVal>0.005078947820</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ligand Pharmaceuticals Inc.</name>
        <lei>5493008K7TB0IKP37H79</lei>
        <title>Ligand Pharmaceuticals Inc.</title>
        <cusip>53220K504</cusip>
        <identifiers>
          <isin value="US53220K5048"/>
        </identifiers>
        <balance>358.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>33075.62000000</valUSD>
        <pctVal>0.162504810758</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Stoke Therapeutics, Inc.</name>
        <lei>549300RD25SS2DIJHJ67</lei>
        <title>Stoke Therapeutics, Inc.</title>
        <cusip>86150R107</cusip>
        <identifiers>
          <isin value="US86150R1077"/>
        </identifiers>
        <balance>817.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>12304.02000000</valUSD>
        <pctVal>0.060451246013</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Amarin Corp. PLC</name>
        <lei>5493009JFIGUFEVPK217</lei>
        <title>Amarin Corp. PLC, ADR</title>
        <cusip>023111206</cusip>
        <identifiers>
          <isin value="US0231112063"/>
        </identifiers>
        <balance>8265.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>9752.70000000</valUSD>
        <pctVal>0.047916279963</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Generation Bio Co.</name>
        <lei>N/A</lei>
        <title>Generation Bio Co.</title>
        <cusip>37148K100</cusip>
        <identifiers>
          <isin value="US37148K1007"/>
        </identifiers>
        <balance>1192.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6103.04000000</valUSD>
        <pctVal>0.029985027045</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Omega Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Omega Therapeutics, Inc.</title>
        <cusip>68217N105</cusip>
        <identifiers>
          <isin value="US68217N1054"/>
        </identifiers>
        <balance>974.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4353.78000000</valUSD>
        <pctVal>0.021390685797</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BioMarin Pharmaceutical Inc.</name>
        <lei>NSLL8ITTRR0J5HEMR848</lei>
        <title>BioMarin Pharmaceutical Inc.</title>
        <cusip>09061G101</cusip>
        <identifiers>
          <isin value="US09061G1013"/>
        </identifiers>
        <balance>3884.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>346452.80000000</valUSD>
        <pctVal>1.702167539134</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Decibel Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Decibel Therapeutics, Inc.</title>
        <cusip>24343R106</cusip>
        <identifiers>
          <isin value="US24343R1068"/>
        </identifiers>
        <balance>522.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2578.68000000</valUSD>
        <pctVal>0.012669389278</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Spectrum Pharmaceuticals, Inc.</name>
        <lei>549300COU30WSP3O5I07</lei>
        <title>Spectrum Pharmaceuticals, Inc.</title>
        <cusip>84763A108</cusip>
        <identifiers>
          <isin value="US84763A1088"/>
        </identifiers>
        <balance>3767.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4256.71000000</valUSD>
        <pctVal>0.020913768298</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Syneos Health, Inc.</name>
        <lei>549300F1ZGKDS8P6GU13</lei>
        <title>Syneos Health, Inc.</title>
        <cusip>87166B102</cusip>
        <identifiers>
          <isin value="US87166B1026"/>
        </identifiers>
        <balance>2150.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>129236.50000000</valUSD>
        <pctVal>0.634955685655</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kymera Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Kymera Therapeutics, Inc.</title>
        <cusip>501575104</cusip>
        <identifiers>
          <isin value="US5015751044"/>
        </identifiers>
        <balance>1087.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>30729.49000000</valUSD>
        <pctVal>0.150977969790</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="30257.12000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Horizon Therapeutics PLC</name>
        <lei>529900P0GSQ79OOZEV53</lei>
        <title>Horizon Therapeutics PLC</title>
        <cusip>G46188101</cusip>
        <identifiers>
          <isin value="IE00BQPVQZ61"/>
        </identifiers>
        <balance>4825.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>285688.25000000</valUSD>
        <pctVal>1.403623424207</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Avadel Pharmaceuticals PLC</name>
        <lei>549300E27PTSG2RHC762</lei>
        <title>Avadel Pharmaceuticals PLC, ADR</title>
        <cusip>05337M104</cusip>
        <identifiers>
          <isin value="US05337M1045"/>
        </identifiers>
        <balance>1230.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>8167.20000000</valUSD>
        <pctVal>0.040126512834</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Merus N.V.</name>
        <lei>549300W8GPUWU8QNU293</lei>
        <title>Merus N.V.</title>
        <cusip>N5749R100</cusip>
        <identifiers>
          <isin value="NL0011606264"/>
        </identifiers>
        <balance>915.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>21667.20000000</valUSD>
        <pctVal>0.106453763698</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Oncorus, Inc.</name>
        <lei>N/A</lei>
        <title>Oncorus, Inc.</title>
        <cusip>68236R103</cusip>
        <identifiers>
          <isin value="US68236R1032"/>
        </identifiers>
        <balance>544.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>707.20000000</valUSD>
        <pctVal>0.003474565319</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Jazz Pharmaceuticals PLC</name>
        <lei>635400GAUMJCLEZRRV50</lei>
        <title>Jazz Pharmaceuticals PLC</title>
        <cusip>G50871105</cusip>
        <identifiers>
          <isin value="IE00B4Q5ZN47"/>
        </identifiers>
        <balance>1308.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>203027.76000000</valUSD>
        <pctVal>0.997501716294</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Quantum-Si Inc.</name>
        <lei>N/A</lei>
        <title>Quantum-Si Inc.</title>
        <cusip>74765K105</cusip>
        <identifiers>
          <isin value="US74765K1051"/>
        </identifiers>
        <balance>2487.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7759.44000000</valUSD>
        <pctVal>0.038123135070</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Spero Therapeutics, Inc.</name>
        <lei>54930074G13LHWJT2323</lei>
        <title>Spero Therapeutics, Inc.</title>
        <cusip>84833T103</cusip>
        <identifiers>
          <isin value="US84833T1034"/>
        </identifiers>
        <balance>659.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>531.75000000</valUSD>
        <pctVal>0.002612556714</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>89Bio, Inc.</name>
        <lei>N/A</lei>
        <title>89Bio, Inc.</title>
        <cusip>282559103</cusip>
        <identifiers>
          <isin value="US2825591033"/>
        </identifiers>
        <balance>827.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3688.42000000</valUSD>
        <pctVal>0.018121685824</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sesen Bio, Inc.</name>
        <lei>549300DGKHONOZQIY116</lei>
        <title>Sesen Bio, Inc.</title>
        <cusip>817763105</cusip>
        <identifiers>
          <isin value="US8177631053"/>
        </identifiers>
        <balance>4170.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2877.30000000</valUSD>
        <pctVal>0.014136548067</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Harpoon Therapeutics, Inc.</name>
        <lei>549300VFZL0TEVXILA36</lei>
        <title>Harpoon Therapeutics, Inc.</title>
        <cusip>41358P106</cusip>
        <identifiers>
          <isin value="US41358P1066"/>
        </identifiers>
        <balance>666.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1105.56000000</valUSD>
        <pctVal>0.005431759664</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1204.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Syros Pharmaceuticals, Inc.</name>
        <lei>549300512PURS7IGVT96</lei>
        <title>Syros Pharmaceuticals, Inc.</title>
        <cusip>87184Q107</cusip>
        <identifiers>
          <isin value="US87184Q1076"/>
        </identifiers>
        <balance>1287.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1030.37000000</valUSD>
        <pctVal>0.005062341442</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Intercept Pharmaceuticals, Inc.</name>
        <lei>254900JMB8TX5P688V24</lei>
        <title>Intercept Pharmaceuticals, Inc.</title>
        <cusip>45845P108</cusip>
        <identifiers>
          <isin value="US45845P1084"/>
        </identifiers>
        <balance>621.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>10786.77000000</valUSD>
        <pctVal>0.052996799985</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="5730.56000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Medpace Holdings, Inc.</name>
        <lei>549300H8TYEUVTW14A54</lei>
        <title>Medpace Holdings, Inc.</title>
        <cusip>58506Q109</cusip>
        <identifiers>
          <isin value="US58506Q1094"/>
        </identifiers>
        <balance>703.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>103769.83000000</valUSD>
        <pctVal>0.509834633079</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Neurocrine Biosciences, Inc.</name>
        <lei>549300FECER0XBN49756</lei>
        <title>Neurocrine Biosciences, Inc.</title>
        <cusip>64125C109</cusip>
        <identifiers>
          <isin value="US64125C1099"/>
        </identifiers>
        <balance>2007.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>209992.41000000</valUSD>
        <pctVal>1.031719945016</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MeiraGTx Holdings PLC</name>
        <lei>54930007YV6NYIOGFZ57</lei>
        <title>MeiraGTx Holdings PLC</title>
        <cusip>G59665102</cusip>
        <identifiers>
          <isin value="KYG596651029"/>
        </identifiers>
        <balance>934.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7752.20000000</valUSD>
        <pctVal>0.038087564011</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AbSci Corp.</name>
        <lei>N/A</lei>
        <title>AbSci Corp.</title>
        <cusip>00091E109</cusip>
        <identifiers>
          <isin value="US00091E1091"/>
        </identifiers>
        <balance>1915.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6453.55000000</valUSD>
        <pctVal>0.031707128134</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="5814.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Insmed Inc.</name>
        <lei>529900Q55QAG41CCAC11</lei>
        <title>Insmed Inc.</title>
        <cusip>457669307</cusip>
        <identifiers>
          <isin value="US4576693075"/>
        </identifiers>
        <balance>2511.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>61820.82000000</valUSD>
        <pctVal>0.303733706428</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Dyne Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Dyne Therapeutics, Inc.</title>
        <cusip>26818M108</cusip>
        <identifiers>
          <isin value="US26818M1080"/>
        </identifiers>
        <balance>1085.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>10633.00000000</valUSD>
        <pctVal>0.052241308032</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Immunic, Inc.</name>
        <lei>549300R5T12FW5MEQB20</lei>
        <title>Immunic, Inc.</title>
        <cusip>4525EP101</cusip>
        <identifiers>
          <isin value="US4525EP1011"/>
        </identifiers>
        <balance>640.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2848.00000000</valUSD>
        <pctVal>0.013992593367</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Rhythm Pharmaceuticals, Inc.</name>
        <lei>529900JPNWXQ8DPLA551</lei>
        <title>Rhythm Pharmaceuticals, Inc.</title>
        <cusip>76243J105</cusip>
        <identifiers>
          <isin value="US76243J1051"/>
        </identifiers>
        <balance>1055.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>23843.00000000</valUSD>
        <pctVal>0.117143751286</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Aerovate Therapeutics Inc.</name>
        <lei>N/A</lei>
        <title>Aerovate Therapeutics Inc.</title>
        <cusip>008064107</cusip>
        <identifiers>
          <isin value="US0080641071"/>
        </identifiers>
        <balance>509.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>10093.47000000</valUSD>
        <pctVal>0.049590527169</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="9914.13000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Compugen Ltd.</name>
        <lei>N/A</lei>
        <title>Compugen Ltd.</title>
        <cusip>M25722105</cusip>
        <identifiers>
          <isin value="IL0010852080"/>
        </identifiers>
        <balance>1812.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2120.04000000</valUSD>
        <pctVal>0.010416031475</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IL</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Biogen Inc.</name>
        <lei>W8J5WZB5IY3K0NDQT671</lei>
        <title>Biogen Inc.</title>
        <cusip>09062X103</cusip>
        <identifiers>
          <isin value="US09062X1037"/>
        </identifiers>
        <balance>3076.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>600988.88000000</valUSD>
        <pctVal>2.952736311892</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Poseida Therapeutics, Inc.</name>
        <lei>549300USKSDMNGMN8V04</lei>
        <title>Poseida Therapeutics, Inc.</title>
        <cusip>73730P108</cusip>
        <identifiers>
          <isin value="US73730P1084"/>
        </identifiers>
        <balance>1822.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6030.82000000</valUSD>
        <pctVal>0.029630200819</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Design Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Design Therapeutics, Inc.</title>
        <cusip>25056L103</cusip>
        <identifiers>
          <isin value="US25056L1035"/>
        </identifiers>
        <balance>1169.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>23683.94000000</valUSD>
        <pctVal>0.116362268877</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="22665.63000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kura Oncology, Inc.</name>
        <lei>5493005QORQTZCZYOP39</lei>
        <title>Kura Oncology, Inc.</title>
        <cusip>50127T109</cusip>
        <identifiers>
          <isin value="US50127T1097"/>
        </identifiers>
        <balance>1398.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>19376.28000000</valUSD>
        <pctVal>0.095198176620</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="19237.60000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>23AndMe Holding Co.</name>
        <lei>N/A</lei>
        <title>23AndMe Holding Co.</title>
        <cusip>90138Q108</cusip>
        <identifiers>
          <isin value="US90138Q1085"/>
        </identifiers>
        <balance>5367.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>18086.79000000</valUSD>
        <pctVal>0.088862745012</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="5504.58000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Nurix Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Nurix Therapeutics, Inc.</title>
        <cusip>67080M103</cusip>
        <identifiers>
          <isin value="US67080M1036"/>
        </identifiers>
        <balance>940.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14786.20000000</valUSD>
        <pctVal>0.072646518276</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="14331.30000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Clearside Biomedical, Inc.</name>
        <lei>529900GQSUZO5HQ9DS29</lei>
        <title>Clearside Biomedical, Inc.</title>
        <cusip>185063104</cusip>
        <identifiers>
          <isin value="US1850631045"/>
        </identifiers>
        <balance>1258.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1723.46000000</valUSD>
        <pctVal>0.008467582501</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Pliant Therapeutics, Inc.</name>
        <lei>5493002Q5LITR7VHZH02</lei>
        <title>Pliant Therapeutics, Inc.</title>
        <cusip>729139105</cusip>
        <identifiers>
          <isin value="US7291391057"/>
        </identifiers>
        <balance>995.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>19183.60000000</valUSD>
        <pctVal>0.094251514791</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Caribou Biosciences, Inc.</name>
        <lei>N/A</lei>
        <title>Caribou Biosciences, Inc.</title>
        <cusip>142038108</cusip>
        <identifiers>
          <isin value="US1420381089"/>
        </identifiers>
        <balance>1272.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>12554.64000000</valUSD>
        <pctVal>0.061682574577</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Royalty Pharma PLC</name>
        <lei>549300FGFN7VOK8BZR03</lei>
        <title>Royalty Pharma PLC, Class A</title>
        <cusip>G7709Q104</cusip>
        <identifiers>
          <isin value="GB00BMVP7Y09"/>
        </identifiers>
        <balance>9136.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>381976.16000000</valUSD>
        <pctVal>1.876698413969</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Phathom Pharmaceuticals, Inc.</name>
        <lei>N/A</lei>
        <title>Phathom Pharmaceuticals, Inc.</title>
        <cusip>71722W107</cusip>
        <identifiers>
          <isin value="US71722W1071"/>
        </identifiers>
        <balance>815.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6960.10000000</valUSD>
        <pctVal>0.034195873980</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="6842.94000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Hutchmed China Ltd.</name>
        <lei>2138006X34YDQ6OBYE79</lei>
        <title>Hutchmed China Ltd., ADR</title>
        <cusip>44842L103</cusip>
        <identifiers>
          <isin value="US44842L1035"/>
        </identifiers>
        <balance>1120.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14403.20000000</valUSD>
        <pctVal>0.070764789603</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Century Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Century Therapeutics, Inc.</title>
        <cusip>15673T100</cusip>
        <identifiers>
          <isin value="US15673T1007"/>
        </identifiers>
        <balance>1228.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>12918.56000000</valUSD>
        <pctVal>0.063470560735</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Immuneering Corp.</name>
        <lei>N/A</lei>
        <title>Immuneering Corp.</title>
        <cusip>45254E107</cusip>
        <identifiers>
          <isin value="US45254E1073"/>
        </identifiers>
        <balance>556.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3102.48000000</valUSD>
        <pctVal>0.015242886612</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1395.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kiniksa Pharmaceuticals, Ltd.</name>
        <lei>N/A</lei>
        <title>Kiniksa Pharmaceuticals, Ltd.</title>
        <cusip>G5269C101</cusip>
        <identifiers>
          <isin value="BMG5269C1010"/>
        </identifiers>
        <balance>715.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>8379.80000000</valUSD>
        <pctVal>0.041171044207</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>BM</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alpha Teknova, Inc.</name>
        <lei>N/A</lei>
        <title>Alpha Teknova, Inc.</title>
        <cusip>02080L102</cusip>
        <identifiers>
          <isin value="US02080L1026"/>
        </identifiers>
        <balance>588.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2651.88000000</valUSD>
        <pctVal>0.013029030372</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Phibro Animal Health Corp.</name>
        <lei>549300U24SP4AF2JUX52</lei>
        <title>Phibro Animal Health Corp.</title>
        <cusip>71742Q106</cusip>
        <identifiers>
          <isin value="US71742Q1067"/>
        </identifiers>
        <balance>426.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6309.06000000</valUSD>
        <pctVal>0.030997230025</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Editas Medicine, Inc.</name>
        <lei>5299000AON4Q9NT2JE42</lei>
        <title>Editas Medicine, Inc.</title>
        <cusip>28106W103</cusip>
        <identifiers>
          <isin value="US28106W1036"/>
        </identifiers>
        <balance>1432.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>21050.40000000</valUSD>
        <pctVal>0.103423345303</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="6441.12000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ironwood Pharmaceuticals, Inc.</name>
        <lei>549300PC8MR6QHH6P296</lei>
        <title>Ironwood Pharmaceuticals, Inc.</title>
        <cusip>46333X108</cusip>
        <identifiers>
          <isin value="US46333X1081"/>
        </identifiers>
        <balance>3239.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>34851.64000000</valUSD>
        <pctVal>0.171230627357</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="34817.16000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Mirati Therapeutics, Inc.</name>
        <lei>529900GYRW59IDQV6N54</lei>
        <title>Mirati Therapeutics, Inc.</title>
        <cusip>60468T105</cusip>
        <identifiers>
          <isin value="US60468T1051"/>
        </identifiers>
        <balance>1167.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>94562.01000000</valUSD>
        <pctVal>0.464595419223</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Seer, Inc.</name>
        <lei>N/A</lei>
        <title>Seer, Inc.</title>
        <cusip>81578P106</cusip>
        <identifiers>
          <isin value="US81578P1066"/>
        </identifiers>
        <balance>1226.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>12382.60000000</valUSD>
        <pctVal>0.060837319744</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="11268.77000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Allogene Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Allogene Therapeutics, Inc.</title>
        <cusip>019770106</cusip>
        <identifiers>
          <isin value="US0197701065"/>
        </identifiers>
        <balance>3022.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>41431.62000000</valUSD>
        <pctVal>0.203558922478</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="40737.42000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Eiger BioPharmaceuticals, Inc.</name>
        <lei>549300GO4VMIHDKJNU46</lei>
        <title>Eiger BioPharmaceuticals, Inc.</title>
        <cusip>28249U105</cusip>
        <identifiers>
          <isin value="US28249U1051"/>
        </identifiers>
        <balance>895.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7392.70000000</valUSD>
        <pctVal>0.036321293886</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Rain Therapeutics Inc.</name>
        <lei>N/A</lei>
        <title>Rain Therapeutics Inc.</title>
        <cusip>75082Q105</cusip>
        <identifiers>
          <isin value="US75082Q1058"/>
        </identifiers>
        <balance>390.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2312.70000000</valUSD>
        <pctVal>0.011362595042</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Edgewise Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Edgewise Therapeutics, Inc.</title>
        <cusip>28036F105</cusip>
        <identifiers>
          <isin value="US28036F1057"/>
        </identifiers>
        <balance>1036.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>10442.88000000</valUSD>
        <pctVal>0.051307223815</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>argenx SE</name>
        <lei>7245009C5FZE6G9ODQ71</lei>
        <title>argenx SE, ADR</title>
        <cusip>04016X101</cusip>
        <identifiers>
          <isin value="US04016X1019"/>
        </identifiers>
        <balance>623.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>235413.01000000</valUSD>
        <pctVal>1.156614649706</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Werewolf Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Werewolf Therapeutics, Inc.</title>
        <cusip>95075A107</cusip>
        <identifiers>
          <isin value="US95075A1079"/>
        </identifiers>
        <balance>583.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2949.98000000</valUSD>
        <pctVal>0.014493634333</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SpringWorks Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>SpringWorks Therapeutics, Inc.</title>
        <cusip>85205L107</cusip>
        <identifiers>
          <isin value="US85205L1070"/>
        </identifiers>
        <balance>1032.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>28658.64000000</valUSD>
        <pctVal>0.140803615164</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="27393.43000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Genmab A/S</name>
        <lei>529900MTJPDPE4MHJ122</lei>
        <title>Genmab A/S, ADR</title>
        <cusip>372303206</cusip>
        <identifiers>
          <isin value="US3723032062"/>
        </identifiers>
        <balance>888.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>31515.12000000</valUSD>
        <pctVal>0.154837871871</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>DK</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Recursion Pharmaceuticals, Inc.</name>
        <lei>N/A</lei>
        <title>Recursion Pharmaceuticals, Inc.</title>
        <cusip>75629V104</cusip>
        <identifiers>
          <isin value="US75629V1044"/>
        </identifiers>
        <balance>3444.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>36196.44000000</valUSD>
        <pctVal>0.177837804169</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Esperion Therapeutics, Inc.</name>
        <lei>549300OFU56UKEWVUS92</lei>
        <title>Esperion Therapeutics, Inc.</title>
        <cusip>29664W105</cusip>
        <identifiers>
          <isin value="US29664W1053"/>
        </identifiers>
        <balance>1335.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>9959.10000000</valUSD>
        <pctVal>0.048930349932</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="9762.19000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Zai Lab Ltd.</name>
        <lei>549300P2UYQ9U5LY1T58</lei>
        <title>Zai Lab Ltd., ADR</title>
        <cusip>98887Q104</cusip>
        <identifiers>
          <isin value="US98887Q1040"/>
        </identifiers>
        <balance>1431.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>66126.51000000</valUSD>
        <pctVal>0.324888119819</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="61397.76000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Curis, Inc.</name>
        <lei>5299000YO6CX4WMFVX06</lei>
        <title>Curis, Inc.</title>
        <cusip>231269200</cusip>
        <identifiers>
          <isin value="US2312692005"/>
        </identifiers>
        <balance>1921.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1863.37000000</valUSD>
        <pctVal>0.009154978477</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Olema Pharmaceuticals, Inc.</name>
        <lei>N/A</lei>
        <title>Olema Pharmaceuticals, Inc.</title>
        <cusip>68062P106</cusip>
        <identifiers>
          <isin value="US68062P1066"/>
        </identifiers>
        <balance>845.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3337.75000000</valUSD>
        <pctVal>0.016398798635</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Revolution Medicines, Inc.</name>
        <lei>549300JU3X0LBCQ65892</lei>
        <title>Revolution Medicines, Inc.</title>
        <cusip>76155X100</cusip>
        <identifiers>
          <isin value="US76155X1000"/>
        </identifiers>
        <balance>1802.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>37535.66000000</valUSD>
        <pctVal>0.184417565717</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Blueprint Medicines Corp.</name>
        <lei>5299004CC60O9T5HVM83</lei>
        <title>Blueprint Medicines Corp.</title>
        <cusip>09627Y109</cusip>
        <identifiers>
          <isin value="US09627Y1091"/>
        </identifiers>
        <balance>1251.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>91598.22000000</valUSD>
        <pctVal>0.450033934569</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Atara Biotherapeutics, Inc.</name>
        <lei>549300WBXUXZRE03MS38</lei>
        <title>Atara Biotherapeutics, Inc.</title>
        <cusip>046513107</cusip>
        <identifiers>
          <isin value="US0465131078"/>
        </identifiers>
        <balance>1928.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7731.28000000</valUSD>
        <pctVal>0.037984781338</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="4185.72000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MacroGenics, Inc.</name>
        <lei>5493001KJQUA83L8MH79</lei>
        <title>MacroGenics, Inc.</title>
        <cusip>556099109</cusip>
        <identifiers>
          <isin value="US5560991094"/>
        </identifiers>
        <balance>1287.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5109.39000000</valUSD>
        <pctVal>0.025103095725</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>TCR2 Therapeutics Inc.</name>
        <lei>5493007TR1ORJAZ8YK34</lei>
        <title>TCR2 Therapeutics Inc.</title>
        <cusip>87808K106</cusip>
        <identifiers>
          <isin value="US87808K1060"/>
        </identifiers>
        <balance>802.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2181.44000000</valUSD>
        <pctVal>0.010717697638</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Myriad Genetics, Inc.</name>
        <lei>52990044IHUOUMETT163</lei>
        <title>Myriad Genetics, Inc.</title>
        <cusip>62855J104</cusip>
        <identifiers>
          <isin value="US62855J1043"/>
        </identifiers>
        <balance>1689.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>37732.26000000</valUSD>
        <pctVal>0.185383487015</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Intra-Cellular Therapies, Inc.</name>
        <lei>5299002U2KGF193IJA20</lei>
        <title>Intra-Cellular Therapies, Inc.</title>
        <cusip>46116X101</cusip>
        <identifiers>
          <isin value="US46116X1019"/>
        </identifiers>
        <balance>1980.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>99514.80000000</valUSD>
        <pctVal>0.488929118839</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>FibroGen, Inc.</name>
        <lei>549300Q914ULWWY95822</lei>
        <title>FibroGen, Inc.</title>
        <cusip>31572Q808</cusip>
        <identifiers>
          <isin value="US31572Q8087"/>
        </identifiers>
        <balance>1959.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>24369.96000000</valUSD>
        <pctVal>0.119732774109</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Codex DNA, Inc.</name>
        <lei>N/A</lei>
        <title>Codex DNA, Inc.</title>
        <cusip>192003101</cusip>
        <identifiers>
          <isin value="US1920031010"/>
        </identifiers>
        <balance>613.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1176.96000000</valUSD>
        <pctVal>0.005782557124</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1218.06000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Rapid Micro Biosystems, Inc.</name>
        <lei>N/A</lei>
        <title>Rapid Micro Biosystems, Inc.</title>
        <cusip>75340L104</cusip>
        <identifiers>
          <isin value="US75340L1044"/>
        </identifiers>
        <balance>765.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2547.45000000</valUSD>
        <pctVal>0.012515952238</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kodiak Sciences Inc.</name>
        <lei>254900IXI5NI8C9OQE24</lei>
        <title>Kodiak Sciences Inc.</title>
        <cusip>50015M109</cusip>
        <identifiers>
          <isin value="US50015M1099"/>
        </identifiers>
        <balance>1092.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>10930.92000000</valUSD>
        <pctVal>0.053705027631</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="11350.50000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Nektar Therapeutics</name>
        <lei>5299005I24806IOIYE03</lei>
        <title>Nektar Therapeutics</title>
        <cusip>640268108</cusip>
        <identifiers>
          <isin value="US6402681083"/>
        </identifiers>
        <balance>4226.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>16650.44000000</valUSD>
        <pctVal>0.081805771176</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="16857.49000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Reata Pharmaceuticals, Inc.</name>
        <lei>5299005F094GH9QDDD80</lei>
        <title>Reata Pharmaceuticals, Inc.</title>
        <cusip>75615P103</cusip>
        <identifiers>
          <isin value="US75615P1030"/>
        </identifiers>
        <balance>664.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>15876.24000000</valUSD>
        <pctVal>0.078002026167</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Theravance Biopharma, Inc.</name>
        <lei>5493007VTSXP4Z6MIW52</lei>
        <title>Theravance Biopharma, Inc.</title>
        <cusip>G8807B106</cusip>
        <identifiers>
          <isin value="KYG8807B1068"/>
        </identifiers>
        <balance>1595.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14370.95000000</valUSD>
        <pctVal>0.070606341171</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Rigel Pharmaceuticals, Inc.</name>
        <lei>529900KPTNUS5J8K9K66</lei>
        <title>Rigel Pharmaceuticals, Inc.</title>
        <cusip>766559603</cusip>
        <identifiers>
          <isin value="US7665596034"/>
        </identifiers>
        <balance>3604.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5117.68000000</valUSD>
        <pctVal>0.025143825570</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>bluebird bio, Inc.</name>
        <lei>N/A</lei>
        <title>bluebird bio, Inc.</title>
        <cusip>09609G100</cusip>
        <identifiers>
          <isin value="US09609G1004"/>
        </identifiers>
        <balance>1499.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>8754.16000000</valUSD>
        <pctVal>0.043010323439</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3657.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Wave Life Sciences Ltd.</name>
        <lei>54930070006GPKFYZ813</lei>
        <title>Wave Life Sciences Ltd.</title>
        <cusip>Y95308105</cusip>
        <identifiers>
          <isin value="SG9999014716"/>
        </identifiers>
        <balance>1820.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5405.40000000</valUSD>
        <pctVal>0.026557431246</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>SG</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Precision BioSciences, Inc.</name>
        <lei>549300I5QGRS3BLHZH41</lei>
        <title>Precision BioSciences, Inc.</title>
        <cusip>74019P108</cusip>
        <identifiers>
          <isin value="US74019P1084"/>
        </identifiers>
        <balance>2351.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3785.11000000</valUSD>
        <pctVal>0.018596736334</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sage Therapeutics, Inc.</name>
        <lei>5493000JX4BJS9W6CN35</lei>
        <title>Sage Therapeutics, Inc.</title>
        <cusip>78667J108</cusip>
        <identifiers>
          <isin value="US78667J1088"/>
        </identifiers>
        <balance>1239.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>46660.74000000</valUSD>
        <pctVal>0.229250267222</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>IDEAYA Biosciences, Inc.</name>
        <lei>549300ULW08F62IJML11</lei>
        <title>IDEAYA Biosciences, Inc.</title>
        <cusip>45166A102</cusip>
        <identifiers>
          <isin value="US45166A1025"/>
        </identifiers>
        <balance>804.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7903.32000000</valUSD>
        <pctVal>0.038830036170</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Twist Bioscience Corp.</name>
        <lei>549300T23BL59LCOH584</lei>
        <title>Twist Bioscience Corp.</title>
        <cusip>90184D100</cusip>
        <identifiers>
          <isin value="US90184D1000"/>
        </identifiers>
        <balance>1184.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>47502.08000000</valUSD>
        <pctVal>0.233383879759</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="46387.76000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alpine Immune Sciences, Inc.</name>
        <lei>5493000845S6RLSDWJ40</lei>
        <title>Alpine Immune Sciences, Inc.</title>
        <cusip>02083G100</cusip>
        <identifiers>
          <isin value="US02083G1004"/>
        </identifiers>
        <balance>635.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4768.85000000</valUSD>
        <pctVal>0.023429978539</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="747.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Cytokinetics, Inc.</name>
        <lei>549300BE5DY1HW7IHA64</lei>
        <title>Cytokinetics, Inc.</title>
        <cusip>23282W605</cusip>
        <identifiers>
          <isin value="US23282W6057"/>
        </identifiers>
        <balance>1797.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>95169.12000000</valUSD>
        <pctVal>0.467578229392</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="90782.37000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Verastem, Inc.</name>
        <lei>549300IY0EFBIU8NQC81</lei>
        <title>Verastem, Inc.</title>
        <cusip>92337C104</cusip>
        <identifiers>
          <isin value="US92337C1045"/>
        </identifiers>
        <balance>3902.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4526.32000000</valUSD>
        <pctVal>0.022238397195</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sera Prognostics, Inc.</name>
        <lei>N/A</lei>
        <title>Sera Prognostics, Inc.</title>
        <cusip>81749D107</cusip>
        <identifiers>
          <isin value="US81749D1072"/>
        </identifiers>
        <balance>616.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1293.60000000</valUSD>
        <pctVal>0.006355624571</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sutro Biopharma, Inc.</name>
        <lei>5493005U6P15VD25P851</lei>
        <title>Sutro Biopharma, Inc.</title>
        <cusip>869367102</cusip>
        <identifiers>
          <isin value="US8693671021"/>
        </identifiers>
        <balance>1093.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6186.38000000</valUSD>
        <pctVal>0.030394487274</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Arcturus Therapeutics Holdings Inc.</name>
        <lei>N/A</lei>
        <title>Arcturus Therapeutics Holdings Inc.</title>
        <cusip>03969T109</cusip>
        <identifiers>
          <isin value="US03969T1097"/>
        </identifiers>
        <balance>557.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7820.28000000</valUSD>
        <pctVal>0.038422049880</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Illumina, Inc.</name>
        <lei>SQ95QG8SR5Q56LSNF682</lei>
        <title>Illumina, Inc.</title>
        <cusip>452327109</cusip>
        <identifiers>
          <isin value="US4523271090"/>
        </identifiers>
        <balance>3273.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>659967.72000000</valUSD>
        <pctVal>3.242507001994</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Exelixis, Inc.</name>
        <lei>254900PJQB59O2O95R37</lei>
        <title>Exelixis, Inc.</title>
        <cusip>30161Q104</cusip>
        <identifiers>
          <isin value="US30161Q1040"/>
        </identifiers>
        <balance>6740.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>119567.60000000</valUSD>
        <pctVal>0.587451125960</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Prothena Corp. PLC</name>
        <lei>5299009ZXQ8NIIJ8OL30</lei>
        <title>Prothena Corp. PLC</title>
        <cusip>G72800108</cusip>
        <identifiers>
          <isin value="IE00B91XRN20"/>
        </identifiers>
        <balance>984.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>27128.88000000</valUSD>
        <pctVal>0.133287705883</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="27262.26000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Fate Therapeutics, Inc.</name>
        <lei>549300L14Q4UHOODLA90</lei>
        <title>Fate Therapeutics, Inc.</title>
        <cusip>31189P102</cusip>
        <identifiers>
          <isin value="US31189P1021"/>
        </identifiers>
        <balance>2034.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>53168.76000000</valUSD>
        <pctVal>0.261225013531</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="52297.74000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Day One Biopharmaceuticals, Inc.</name>
        <lei>N/A</lei>
        <title>Day One Biopharmaceuticals, Inc.</title>
        <cusip>23954D109</cusip>
        <identifiers>
          <isin value="US23954D1090"/>
        </identifiers>
        <balance>1513.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>35540.37000000</valUSD>
        <pctVal>0.174614447170</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="549.84000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Galapagos N.V.</name>
        <lei>549300QKJ78IY0IOV655</lei>
        <title>Galapagos N.V., ADR</title>
        <cusip>36315X101</cusip>
        <identifiers>
          <isin value="US36315X1019"/>
        </identifiers>
        <balance>285.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14267.10000000</valUSD>
        <pctVal>0.070096112652</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>BE</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Replimune Group, Inc.</name>
        <lei>549300AY704NEIRC4K64</lei>
        <title>Replimune Group, Inc.</title>
        <cusip>76029N106</cusip>
        <identifiers>
          <isin value="US76029N1063"/>
        </identifiers>
        <balance>1024.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>19517.44000000</valUSD>
        <pctVal>0.095891714008</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Coherus BioSciences, Inc.</name>
        <lei>5493007IL8W5MV932D26</lei>
        <title>Coherus BioSciences, Inc.</title>
        <cusip>19249H103</cusip>
        <identifiers>
          <isin value="US19249H1032"/>
        </identifiers>
        <balance>1629.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>18212.22000000</valUSD>
        <pctVal>0.089478998869</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="18392.92000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Janux Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Janux Therapeutics, Inc.</title>
        <cusip>47103J105</cusip>
        <identifiers>
          <isin value="US47103J1051"/>
        </identifiers>
        <balance>875.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>9467.50000000</valUSD>
        <pctVal>0.046515055374</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Centessa Pharmaceuticals PLC</name>
        <lei>213800GIDAARDSKOI827</lei>
        <title>Centessa Pharmaceuticals PLC, ADR</title>
        <cusip>152309100</cusip>
        <identifiers>
          <isin value="US1523091007"/>
        </identifiers>
        <balance>1024.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4454.40000000</valUSD>
        <pctVal>0.021885044907</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>NovoCure Ltd.</name>
        <lei>213800YPP55UMHWA4826</lei>
        <title>NovoCure Ltd.</title>
        <cusip>G6674U108</cusip>
        <identifiers>
          <isin value="JE00BYSS4X48"/>
        </identifiers>
        <balance>2195.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>180275.35000000</valUSD>
        <pctVal>0.885716175121</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>JE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="176099.92000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Castle Biosciences, Inc.</name>
        <lei>N/A</lei>
        <title>Castle Biosciences, Inc.</title>
        <cusip>14843C105</cusip>
        <identifiers>
          <isin value="US14843C1053"/>
        </identifiers>
        <balance>553.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>16037.00000000</valUSD>
        <pctVal>0.078791860897</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Xenon Pharmaceuticals Inc.</name>
        <lei>549300XV44Q9Z1MIPQ03</lei>
        <title>Xenon Pharmaceuticals Inc.</title>
        <cusip>98420N105</cusip>
        <identifiers>
          <isin value="CA98420N1050"/>
        </identifiers>
        <balance>1305.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>50647.05000000</valUSD>
        <pctVal>0.248835525251</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Enanta Pharmaceuticals, Inc.</name>
        <lei>529900SSN4DODDQSN594</lei>
        <title>Enanta Pharmaceuticals, Inc.</title>
        <cusip>29251M106</cusip>
        <identifiers>
          <isin value="US29251M1062"/>
        </identifiers>
        <balance>435.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>26482.80000000</valUSD>
        <pctVal>0.130113431051</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Amicus Therapeutics, Inc.</name>
        <lei>549300MRD1SMUTNBPQ53</lei>
        <title>Amicus Therapeutics, Inc.</title>
        <cusip>03152W109</cusip>
        <identifiers>
          <isin value="US03152W1099"/>
        </identifiers>
        <balance>5887.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>66111.01000000</valUSD>
        <pctVal>0.324811966309</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Cullinan Oncology, Inc.</name>
        <lei>N/A</lei>
        <title>Cullinan Oncology, Inc.</title>
        <cusip>230031106</cusip>
        <identifiers>
          <isin value="US2300311063"/>
        </identifiers>
        <balance>936.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>12617.28000000</valUSD>
        <pctVal>0.061990333021</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PTC Therapeutics, Inc.</name>
        <lei>549300UJLWOIWFDGB318</lei>
        <title>PTC Therapeutics, Inc.</title>
        <cusip>69366J200</cusip>
        <identifiers>
          <isin value="US69366J2006"/>
        </identifiers>
        <balance>1502.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>75009.88000000</valUSD>
        <pctVal>0.368533268746</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ultragenyx Pharmaceutical Inc.</name>
        <lei>529900EV44GVDN1DCX77</lei>
        <title>Ultragenyx Pharmaceutical Inc.</title>
        <cusip>90400D108</cusip>
        <identifiers>
          <isin value="US90400D1081"/>
        </identifiers>
        <balance>1470.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>70104.30000000</valUSD>
        <pctVal>0.344431517983</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BELLUS Health Inc.</name>
        <lei>549300QZYQDSMOXCP667</lei>
        <title>BELLUS Health Inc.</title>
        <cusip>07987C204</cusip>
        <identifiers>
          <isin value="CA07987C2040"/>
        </identifiers>
        <balance>2577.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>29377.80000000</valUSD>
        <pctVal>0.144336941514</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Seres Therapeutics, Inc.</name>
        <lei>549300GMXBE5NUWISF13</lei>
        <title>Seres Therapeutics, Inc.</title>
        <cusip>81750R102</cusip>
        <identifiers>
          <isin value="US81750R1023"/>
        </identifiers>
        <balance>2592.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>13322.88000000</valUSD>
        <pctVal>0.065457037333</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Shattuck Labs, Inc.</name>
        <lei>N/A</lei>
        <title>Shattuck Labs, Inc.</title>
        <cusip>82024L103</cusip>
        <identifiers>
          <isin value="US82024L1035"/>
        </identifiers>
        <balance>914.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2970.50000000</valUSD>
        <pctVal>0.014594451755</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Abcam PLC</name>
        <lei>213800B9N83DSNT33F79</lei>
        <title>Abcam PLC, ADR</title>
        <cusip>000380204</cusip>
        <identifiers>
          <isin value="US0003802040"/>
        </identifiers>
        <balance>516.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7698.72000000</valUSD>
        <pctVal>0.037824809835</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Nuvalent, Inc.</name>
        <lei>N/A</lei>
        <title>Nuvalent, Inc.</title>
        <cusip>670703107</cusip>
        <identifiers>
          <isin value="US6707031075"/>
        </identifiers>
        <balance>901.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>15208.88000000</valUSD>
        <pctVal>0.074723199935</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3215.52000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Frequency Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Frequency Therapeutics, Inc.</title>
        <cusip>35803L108</cusip>
        <identifiers>
          <isin value="US35803L1089"/>
        </identifiers>
        <balance>731.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1505.86000000</valUSD>
        <pctVal>0.007398485480</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Magenta Therapeutics, Inc.</name>
        <lei>549300Z3N6ODPCOFC890</lei>
        <title>Magenta Therapeutics, Inc.</title>
        <cusip>55910K108</cusip>
        <identifiers>
          <isin value="US55910K1088"/>
        </identifiers>
        <balance>1226.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2157.76000000</valUSD>
        <pctVal>0.010601354727</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Codexis, Inc.</name>
        <lei>N/A</lei>
        <title>Codexis, Inc.</title>
        <cusip>192005106</cusip>
        <identifiers>
          <isin value="US1920051067"/>
        </identifiers>
        <balance>1367.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>9582.67000000</valUSD>
        <pctVal>0.047080900521</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Cabaletta Bio, Inc.</name>
        <lei>N/A</lei>
        <title>Cabaletta Bio, Inc.</title>
        <cusip>12674W109</cusip>
        <identifiers>
          <isin value="US12674W1099"/>
        </identifiers>
        <balance>603.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>575.80000000</valUSD>
        <pctVal>0.002828980077</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Eagle Pharmaceuticals, Inc.</name>
        <lei>549300TN20OLYTJVP152</lei>
        <title>Eagle Pharmaceuticals, Inc.</title>
        <cusip>269796108</cusip>
        <identifiers>
          <isin value="US2697961082"/>
        </identifiers>
        <balance>265.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>8684.05000000</valUSD>
        <pctVal>0.042665863916</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Leap Therapeutics, Inc.</name>
        <lei>549300T31SMMJ2DDLI13</lei>
        <title>Leap Therapeutics, Inc.</title>
        <cusip>52187K101</cusip>
        <identifiers>
          <isin value="US52187K1016"/>
        </identifiers>
        <balance>2153.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3057.26000000</valUSD>
        <pctVal>0.015020714887</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="2962.09000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kinnate Biopharma Inc.</name>
        <lei>549300YVIWV7HJ5WHI66</lei>
        <title>Kinnate Biopharma Inc.</title>
        <cusip>49705R105</cusip>
        <identifiers>
          <isin value="US49705R1059"/>
        </identifiers>
        <balance>917.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>13278.16000000</valUSD>
        <pctVal>0.065237322173</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Tonix Pharmaceuticals Holding Corp.</name>
        <lei>529900ACPKP9QW20GX48</lei>
        <title>Tonix Pharmaceuticals Holding Corp.</title>
        <cusip>890260862</cusip>
        <identifiers>
          <isin value="US8902608624"/>
        </identifiers>
        <balance>881.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>898.62000000</valUSD>
        <pctVal>0.004415036605</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Optinose, Inc.</name>
        <lei>549300CPBME7Z3CYMN16</lei>
        <title>Optinose, Inc.</title>
        <cusip>68404V100</cusip>
        <identifiers>
          <isin value="US68404V1008"/>
        </identifiers>
        <balance>1758.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6416.70000000</valUSD>
        <pctVal>0.031526079305</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>INVESCO PRIVATE GOVERNMENT FUND</name>
        <lei>N/A</lei>
        <title>INVESCO PRIVATE GOVERNMENT FUND</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="CADIS_ID" value="2442116"/>
        </identifiers>
        <balance>749197.68000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>749197.68000000</valUSD>
        <pctVal>3.680905368035</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>PF</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="749197.68000000" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>UroGen Pharma Ltd.</name>
        <lei>549300C0YCX7CG2G5D50</lei>
        <title>UroGen Pharma Ltd.</title>
        <cusip>M96088105</cusip>
        <identifiers>
          <isin value="IL0011407140"/>
        </identifiers>
        <balance>482.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3590.90000000</valUSD>
        <pctVal>0.017642557416</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IL</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Landos Biopharma, Inc.</name>
        <lei>N/A</lei>
        <title>Landos Biopharma, Inc.</title>
        <cusip>515069102</cusip>
        <identifiers>
          <isin value="US5150691021"/>
        </identifiers>
        <balance>843.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>758.70000000</valUSD>
        <pctVal>0.003727591498</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>atai Life Sciences N.V.</name>
        <lei>391200Z8UWPJSNBNCA11</lei>
        <title>atai Life Sciences N.V.</title>
        <cusip>N0731H103</cusip>
        <identifiers>
          <isin value="NL0015000DX5"/>
        </identifiers>
        <balance>3364.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>15138.00000000</valUSD>
        <pctVal>0.074374957302</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Mirum Pharmaceuticals, Inc.</name>
        <lei>254900YZKR40F7F27K81</lei>
        <title>Mirum Pharmaceuticals, Inc.</title>
        <cusip>604749101</cusip>
        <identifiers>
          <isin value="US6047491013"/>
        </identifiers>
        <balance>769.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>19209.62000000</valUSD>
        <pctVal>0.094379354426</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="14005.40000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Oncocyte Corp.</name>
        <lei>549300BIYAW8GO410287</lei>
        <title>Oncocyte Corp.</title>
        <cusip>68235C107</cusip>
        <identifiers>
          <isin value="US68235C1071"/>
        </identifiers>
        <balance>2454.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1938.66000000</valUSD>
        <pctVal>0.009524888011</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Lexicon Pharmaceuticals, Inc.</name>
        <lei>N/A</lei>
        <title>Lexicon Pharmaceuticals, Inc.</title>
        <cusip>528872302</cusip>
        <identifiers>
          <isin value="US5288723027"/>
        </identifiers>
        <balance>3815.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>10491.25000000</valUSD>
        <pctVal>0.051544871898</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ObsEva S.A.</name>
        <lei>549300PNZ0UEJVKN1618</lei>
        <title>ObsEva S.A.</title>
        <cusip>H5861P103</cusip>
        <identifiers>
          <isin value="CH0346177709"/>
        </identifiers>
        <balance>1747.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>313.76000000</valUSD>
        <pctVal>0.001541543572</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CH</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Pacira BioSciences, Inc.</name>
        <lei>N/A</lei>
        <title>Pacira BioSciences, Inc.</title>
        <cusip>695127100</cusip>
        <identifiers>
          <isin value="US6951271005"/>
        </identifiers>
        <balance>956.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>50170.88000000</valUSD>
        <pctVal>0.246496040285</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Pacific Biosciences of California, Inc.</name>
        <lei>529900F1BWRE1M0KZN89</lei>
        <title>Pacific Biosciences of California, Inc.</title>
        <cusip>69404D108</cusip>
        <identifiers>
          <isin value="US69404D1081"/>
        </identifiers>
        <balance>4691.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>27489.26000000</valUSD>
        <pctVal>0.135058299562</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="25683.27000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AstraZeneca PLC</name>
        <lei>PY6ZZQWO2IZFZC3IOL08</lei>
        <title>AstraZeneca PLC, ADR</title>
        <cusip>046353108</cusip>
        <identifiers>
          <isin value="US0463531089"/>
        </identifiers>
        <balance>11787.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>735273.06000000</valUSD>
        <pctVal>3.612491904040</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Aerie Pharmaceuticals, Inc.</name>
        <lei>529900SFXHDHUO324R09</lei>
        <title>Aerie Pharmaceuticals, Inc.</title>
        <cusip>00771V108</cusip>
        <identifiers>
          <isin value="US00771V1089"/>
        </identifiers>
        <balance>1013.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>15296.30000000</valUSD>
        <pctVal>0.075152705733</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Inhibrx, Inc.</name>
        <lei>549300VBKG2LTV1TLY22</lei>
        <title>Inhibrx, Inc.</title>
        <cusip>45720L107</cusip>
        <identifiers>
          <isin value="US45720L1070"/>
        </identifiers>
        <balance>814.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14440.36000000</valUSD>
        <pctVal>0.070947361503</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="10710.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MaxCyte, Inc.</name>
        <lei>54930053YHXULRFCU991</lei>
        <title>MaxCyte, Inc.</title>
        <cusip>57777K106</cusip>
        <identifiers>
          <isin value="US57777K1060"/>
        </identifiers>
        <balance>2128.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>11065.60000000</valUSD>
        <pctVal>0.054366727938</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ikena Oncology, Inc.</name>
        <lei>N/A</lei>
        <title>Ikena Oncology, Inc.</title>
        <cusip>45175G108</cusip>
        <identifiers>
          <isin value="US45175G1085"/>
        </identifiers>
        <balance>760.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3610.00000000</valUSD>
        <pctVal>0.017736398194</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Xencor, Inc.</name>
        <lei>549300V5IF65437JKG30</lei>
        <title>Xencor, Inc.</title>
        <cusip>98401F105</cusip>
        <identifiers>
          <isin value="US98401F1057"/>
        </identifiers>
        <balance>1252.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>33040.28000000</valUSD>
        <pctVal>0.162331180755</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Viracta Therapeutics, Inc.</name>
        <lei>549300O5S543GE2D9G67</lei>
        <title>Viracta Therapeutics, Inc.</title>
        <cusip>92765F108</cusip>
        <identifiers>
          <isin value="US92765F1084"/>
        </identifiers>
        <balance>812.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3288.60000000</valUSD>
        <pctVal>0.016157318310</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sarepta Therapeutics, Inc.</name>
        <lei>549300IKDPIED8J8IG21</lei>
        <title>Sarepta Therapeutics, Inc.</title>
        <cusip>803607100</cusip>
        <identifiers>
          <isin value="US8036071004"/>
        </identifiers>
        <balance>1841.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>201368.58000000</valUSD>
        <pctVal>0.989349949769</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Arcutis Biotherapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Arcutis Biotherapeutics, Inc.</title>
        <cusip>03969K108</cusip>
        <identifiers>
          <isin value="US03969K1088"/>
        </identifiers>
        <balance>1260.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>33957.00000000</valUSD>
        <pctVal>0.166835145007</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="29862.17000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Allovir, Inc.</name>
        <lei>N/A</lei>
        <title>Allovir, Inc.</title>
        <cusip>019818103</cusip>
        <identifiers>
          <isin value="US0198181036"/>
        </identifiers>
        <balance>1941.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14576.91000000</valUSD>
        <pctVal>0.071618249362</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Deciphera Pharmaceuticals, Inc.</name>
        <lei>529900QR4WAPYY0CBF25</lei>
        <title>Deciphera Pharmaceuticals, Inc.</title>
        <cusip>24344T101</cusip>
        <identifiers>
          <isin value="US24344T1016"/>
        </identifiers>
        <balance>1388.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>22527.24000000</valUSD>
        <pctVal>0.110679251760</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="22135.14000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Bioventus Inc.</name>
        <lei>N/A</lei>
        <title>Bioventus Inc.</title>
        <cusip>09075A108</cusip>
        <identifiers>
          <isin value="US09075A1088"/>
        </identifiers>
        <balance>1287.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>9407.97000000</valUSD>
        <pctVal>0.046222576764</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Summit Therapeutics Inc.</name>
        <lei>N/A</lei>
        <title>Summit Therapeutics Inc.</title>
        <cusip>86627T108</cusip>
        <identifiers>
          <isin value="US86627T1088"/>
        </identifiers>
        <balance>2026.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2431.20000000</valUSD>
        <pctVal>0.011944800911</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Corvus Pharmaceuticals, Inc.</name>
        <lei>549300I3AVJ8F75NCX65</lei>
        <title>Corvus Pharmaceuticals, Inc.</title>
        <cusip>221015100</cusip>
        <identifiers>
          <isin value="US2210151005"/>
        </identifiers>
        <balance>978.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>937.41000000</valUSD>
        <pctVal>0.004605616906</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sensei Biotherapeutics, Inc.</name>
        <lei>8945002MP2CXKAENWU30</lei>
        <title>Sensei Biotherapeutics, Inc.</title>
        <cusip>81728A108</cusip>
        <identifiers>
          <isin value="US81728A1088"/>
        </identifiers>
        <balance>642.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1226.22000000</valUSD>
        <pctVal>0.006024577892</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Atea Pharmaceuticals, Inc.</name>
        <lei>N/A</lei>
        <title>Atea Pharmaceuticals, Inc.</title>
        <cusip>04683R106</cusip>
        <identifiers>
          <isin value="US04683R1068"/>
        </identifiers>
        <balance>1745.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>13087.50000000</valUSD>
        <pctVal>0.064300584865</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="13125.20000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Collegium Pharmaceutical, Inc.</name>
        <lei>54930049FXZMTLW8D496</lei>
        <title>Collegium Pharmaceutical, Inc.</title>
        <cusip>19459J104</cusip>
        <identifiers>
          <isin value="US19459J1043"/>
        </identifiers>
        <balance>708.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>12446.64000000</valUSD>
        <pctVal>0.061151956570</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Evolus, Inc.</name>
        <lei>549300VYQRYBQOT8V419</lei>
        <title>Evolus, Inc.</title>
        <cusip>30052C107</cusip>
        <identifiers>
          <isin value="US30052C1071"/>
        </identifiers>
        <balance>1175.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>11291.75000000</valUSD>
        <pctVal>0.055477832218</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="11920.75000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Iovance Biotherapeutics, Inc.</name>
        <lei>549300220Z2GHH33XL82</lei>
        <title>Iovance Biotherapeutics, Inc.</title>
        <cusip>462260100</cusip>
        <identifiers>
          <isin value="US4622601007"/>
        </identifiers>
        <balance>3293.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>35300.96000000</valUSD>
        <pctVal>0.173438194791</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="34067.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Forma Therapeutics Holdings, Inc.</name>
        <lei>N/A</lei>
        <title>Forma Therapeutics Holdings, Inc.</title>
        <cusip>34633R104</cusip>
        <identifiers>
          <isin value="US34633R1041"/>
        </identifiers>
        <balance>1005.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>13467.00000000</valUSD>
        <pctVal>0.066165117584</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sangamo Therapeutics, Inc.</name>
        <lei>2549006WMRKRC4G32Z67</lei>
        <title>Sangamo Therapeutics, Inc.</title>
        <cusip>800677106</cusip>
        <identifiers>
          <isin value="US8006771062"/>
        </identifiers>
        <balance>3073.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>16594.20000000</valUSD>
        <pctVal>0.081529456762</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="16213.86000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Biomea Fusion, Inc.</name>
        <lei>N/A</lei>
        <title>Biomea Fusion, Inc.</title>
        <cusip>09077A106</cusip>
        <identifiers>
          <isin value="US09077A1060"/>
        </identifiers>
        <balance>608.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6992.00000000</valUSD>
        <pctVal>0.034352602818</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Quince Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Quince Therapeutics, Inc.</title>
        <cusip>22053A107</cusip>
        <identifiers>
          <isin value="US22053A1079"/>
        </identifiers>
        <balance>748.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1316.48000000</valUSD>
        <pctVal>0.006468036979</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Annexon, Inc.</name>
        <lei>N/A</lei>
        <title>Annexon, Inc.</title>
        <cusip>03589W102</cusip>
        <identifiers>
          <isin value="US03589W1027"/>
        </identifiers>
        <balance>1013.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5956.44000000</valUSD>
        <pctVal>0.029264762232</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Syndax Pharmaceuticals, Inc.</name>
        <lei>529900OF94TRHKZVBS87</lei>
        <title>Syndax Pharmaceuticals, Inc.</title>
        <cusip>87164F105</cusip>
        <identifiers>
          <isin value="US87164F1057"/>
        </identifiers>
        <balance>1180.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>27859.80000000</valUSD>
        <pctVal>0.136878810639</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Black Diamond Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Black Diamond Therapeutics, Inc.</title>
        <cusip>09203E105</cusip>
        <identifiers>
          <isin value="US09203E1055"/>
        </identifiers>
        <balance>763.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2433.97000000</valUSD>
        <pctVal>0.011958410280</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="2423.55000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Karyopharm Therapeutics Inc.</name>
        <lei>549300J1VANRCNTYST87</lei>
        <title>Karyopharm Therapeutics Inc.</title>
        <cusip>48576U106</cusip>
        <identifiers>
          <isin value="US48576U1060"/>
        </identifiers>
        <balance>1659.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>8394.54000000</valUSD>
        <pctVal>0.041243463738</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="156.24000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alnylam Pharmaceuticals, Inc.</name>
        <lei>529900S3ZI14OWRJII50</lei>
        <title>Alnylam Pharmaceuticals, Inc.</title>
        <cusip>02043Q107</cusip>
        <identifiers>
          <isin value="US02043Q1076"/>
        </identifiers>
        <balance>2537.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>524321.79000000</valUSD>
        <pctVal>2.576060955486</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Vaxcyte, Inc.</name>
        <lei>254900M7NMHTGASX8D95</lei>
        <title>Vaxcyte, Inc.</title>
        <cusip>92243G108</cusip>
        <identifiers>
          <isin value="US92243G1085"/>
        </identifiers>
        <balance>1223.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>31993.68000000</valUSD>
        <pctVal>0.157189099217</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ChemoCentryx, Inc.</name>
        <lei>529900YTTXUSFQTAKY40</lei>
        <title>ChemoCentryx, Inc.</title>
        <cusip>16383L106</cusip>
        <identifiers>
          <isin value="US16383L1061"/>
        </identifiers>
        <balance>1492.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>76062.16000000</valUSD>
        <pctVal>0.373703256860</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Keros Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Keros Therapeutics, Inc.</title>
        <cusip>492327101</cusip>
        <identifiers>
          <isin value="US4923271013"/>
        </identifiers>
        <balance>500.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>17685.00000000</valUSD>
        <pctVal>0.086888698632</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ascendis Pharma A/S</name>
        <lei>549300B66JN3W3J8GH73</lei>
        <title>Ascendis Pharma A/S, ADR</title>
        <cusip>04351P101</cusip>
        <identifiers>
          <isin value="US04351P1012"/>
        </identifiers>
        <balance>1166.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>104438.62000000</valUSD>
        <pctVal>0.513120485087</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>DK</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Novavax, Inc.</name>
        <lei>529900J4GJHPEPQ23205</lei>
        <title>Novavax, Inc.</title>
        <cusip>670002401</cusip>
        <identifiers>
          <isin value="US6700024010"/>
        </identifiers>
        <balance>1638.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>54119.52000000</valUSD>
        <pctVal>0.265896220719</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="915.72000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Beam Therapeutics Inc.</name>
        <lei>254900QL5GLNKGR8YH71</lei>
        <title>Beam Therapeutics Inc.</title>
        <cusip>07373V105</cusip>
        <identifiers>
          <isin value="US07373V1052"/>
        </identifiers>
        <balance>1474.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>80480.40000000</valUSD>
        <pctVal>0.395410642998</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="56337.68000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Taysha Gene Therapies, Inc.</name>
        <lei>N/A</lei>
        <title>Taysha Gene Therapies, Inc.</title>
        <cusip>877619106</cusip>
        <identifiers>
          <isin value="US8776191061"/>
        </identifiers>
        <balance>850.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2686.00000000</valUSD>
        <pctVal>0.013196666357</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Agios Pharmaceuticals, Inc.</name>
        <lei>529900ONJHY8EOGYT555</lei>
        <title>Agios Pharmaceuticals, Inc.</title>
        <cusip>00847X104</cusip>
        <identifiers>
          <isin value="US00847X1046"/>
        </identifiers>
        <balance>1145.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>29197.50000000</valUSD>
        <pctVal>0.143451104230</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="548.68000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Axsome Therapeutics, Inc.</name>
        <lei>549300EXGR0XLRJEIB95</lei>
        <title>Axsome Therapeutics, Inc.</title>
        <cusip>05464T104</cusip>
        <identifiers>
          <isin value="US05464T1043"/>
        </identifiers>
        <balance>817.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>52124.60000000</valUSD>
        <pctVal>0.256094920030</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ALX Oncology Holdings Inc.</name>
        <lei>N/A</lei>
        <title>ALX Oncology Holdings Inc.</title>
        <cusip>00166B105</cusip>
        <identifiers>
          <isin value="US00166B1052"/>
        </identifiers>
        <balance>853.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>11089.00000000</valUSD>
        <pctVal>0.054481695173</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="10307.10000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Humacyte, Inc.</name>
        <lei>N/A</lei>
        <title>Humacyte, Inc.</title>
        <cusip>44486Q103</cusip>
        <identifiers>
          <isin value="US44486Q1031"/>
        </identifiers>
        <balance>2128.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7767.20000000</valUSD>
        <pctVal>0.038161260956</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="5880.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ADMA Biologics, Inc.</name>
        <lei>N/A</lei>
        <title>ADMA Biologics, Inc.</title>
        <cusip>000899104</cusip>
        <identifiers>
          <isin value="US0008991046"/>
        </identifiers>
        <balance>4111.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>11099.70000000</valUSD>
        <pctVal>0.054534265660</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="10742.16000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Imago BioSciences, Inc.</name>
        <lei>N/A</lei>
        <title>Imago BioSciences, Inc.</title>
        <cusip>45250K107</cusip>
        <identifiers>
          <isin value="US45250K1079"/>
        </identifiers>
        <balance>702.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>10200.06000000</valUSD>
        <pctVal>0.050114217663</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3508.92000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CymaBay Therapeutics, Inc.</name>
        <lei>549300YT9GNL852E7F84</lei>
        <title>CymaBay Therapeutics, Inc.</title>
        <cusip>23257D103</cusip>
        <identifiers>
          <isin value="US23257D1037"/>
        </identifiers>
        <balance>1770.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6265.80000000</valUSD>
        <pctVal>0.030784688034</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Harvard Bioscience Inc.</name>
        <lei>549300VLGB1D47GGC642</lei>
        <title>Harvard Bioscience Inc.</title>
        <cusip>416906105</cusip>
        <identifiers>
          <isin value="US4169061052"/>
        </identifiers>
        <balance>866.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2857.80000000</valUSD>
        <pctVal>0.014040742038</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Graphite Bio, Inc.</name>
        <lei>N/A</lei>
        <title>Graphite Bio, Inc.</title>
        <cusip>38870X104</cusip>
        <identifiers>
          <isin value="US38870X1046"/>
        </identifiers>
        <balance>1186.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3925.66000000</valUSD>
        <pctVal>0.019287276713</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Crinetics Pharmaceuticals, Inc.</name>
        <lei>549300Q1CNFXK5P31D28</lei>
        <title>Crinetics Pharmaceuticals, Inc.</title>
        <cusip>22663K107</cusip>
        <identifiers>
          <isin value="US22663K1079"/>
        </identifiers>
        <balance>1115.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>21051.20000000</valUSD>
        <pctVal>0.103427275807</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="20957.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ProQR Therapeutics N.V.</name>
        <lei>549300NGS2FJGGDBGS06</lei>
        <title>ProQR Therapeutics N.V.</title>
        <cusip>N71542109</cusip>
        <identifiers>
          <isin value="NL0010872495"/>
        </identifiers>
        <balance>1496.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1181.69000000</valUSD>
        <pctVal>0.005805796227</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Repare Therapeutics Inc.</name>
        <lei>N/A</lei>
        <title>Repare Therapeutics Inc.</title>
        <cusip>760273102</cusip>
        <identifiers>
          <isin value="US7602731025"/>
        </identifiers>
        <balance>882.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>10513.44000000</valUSD>
        <pctVal>0.051653894246</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alector, Inc.</name>
        <lei>549300Z8RQOIY1JMHC25</lei>
        <title>Alector, Inc.</title>
        <cusip>014442107</cusip>
        <identifiers>
          <isin value="US0144421072"/>
        </identifiers>
        <balance>1736.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>17967.60000000</valUSD>
        <pctVal>0.088277149083</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="18210.80000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AnaptysBio, Inc.</name>
        <lei>529900HH4WQT03IG1A12</lei>
        <title>AnaptysBio, Inc.</title>
        <cusip>032724106</cusip>
        <identifiers>
          <isin value="US0327241065"/>
        </identifiers>
        <balance>592.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>13746.24000000</valUSD>
        <pctVal>0.067537059920</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="13923.36000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Chimerix, Inc.</name>
        <lei>5299002IR2GXUBEPKS66</lei>
        <title>Chimerix, Inc.</title>
        <cusip>16934W106</cusip>
        <identifiers>
          <isin value="US16934W1062"/>
        </identifiers>
        <balance>1857.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4085.40000000</valUSD>
        <pctVal>0.020072100050</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Arvinas, Inc.</name>
        <lei>N/A</lei>
        <title>Arvinas, Inc.</title>
        <cusip>04335A105</cusip>
        <identifiers>
          <isin value="US04335A1051"/>
        </identifiers>
        <balance>1115.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>47209.10000000</valUSD>
        <pctVal>0.231944431021</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="24577.69000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kezar Life Sciences, Inc.</name>
        <lei>549300EV1V8GXBV18004</lei>
        <title>Kezar Life Sciences, Inc.</title>
        <cusip>49372L100</cusip>
        <identifiers>
          <isin value="US49372L1008"/>
        </identifiers>
        <balance>1427.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14669.56000000</valUSD>
        <pctVal>0.072073450829</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="2952.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Geron Corp.</name>
        <lei>549300T282D7Z2YESL90</lei>
        <title>Geron Corp.</title>
        <cusip>374163103</cusip>
        <identifiers>
          <isin value="US3741631036"/>
        </identifiers>
        <balance>7901.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>20858.64000000</valUSD>
        <pctVal>0.102481203553</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Vanda Pharmaceuticals Inc.</name>
        <lei>529900AY8VOOQBKJ0O70</lei>
        <title>Vanda Pharmaceuticals Inc.</title>
        <cusip>921659108</cusip>
        <identifiers>
          <isin value="US9216591084"/>
        </identifiers>
        <balance>1186.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>12547.88000000</valUSD>
        <pctVal>0.061649361820</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Aquestive Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Aquestive Therapeutics, Inc.</title>
        <cusip>03843E104</cusip>
        <identifiers>
          <isin value="US03843E1047"/>
        </identifiers>
        <balance>1050.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1517.25000000</valUSD>
        <pctVal>0.007454446027</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Marinus Pharmaceuticals, Inc.</name>
        <lei>549300NCT4OJF7JV1084</lei>
        <title>Marinus Pharmaceuticals, Inc.</title>
        <cusip>56854Q200</cusip>
        <identifiers>
          <isin value="US56854Q2003"/>
        </identifiers>
        <balance>774.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5387.04000000</valUSD>
        <pctVal>0.026467226184</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>NanoString Technologies, Inc.</name>
        <lei>549300G4CK0Y3WRDMY89</lei>
        <title>NanoString Technologies, Inc.</title>
        <cusip>63009R109</cusip>
        <identifiers>
          <isin value="US63009R1095"/>
        </identifiers>
        <balance>975.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>13221.00000000</valUSD>
        <pctVal>0.064956487679</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="2823.10000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Autolus Therapeutics PLC</name>
        <lei>549300C0KZP8EYROLL02</lei>
        <title>Autolus Therapeutics PLC, ADR</title>
        <cusip>05280R100</cusip>
        <identifiers>
          <isin value="US05280R1005"/>
        </identifiers>
        <balance>1183.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3903.90000000</valUSD>
        <pctVal>0.019180367011</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3042.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ACADIA Pharmaceuticals Inc.</name>
        <lei>529900O3044NO0PEA039</lei>
        <title>ACADIA Pharmaceuticals Inc.</title>
        <cusip>004225108</cusip>
        <identifiers>
          <isin value="US0042251084"/>
        </identifiers>
        <balance>3394.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>55763.42000000</valUSD>
        <pctVal>0.273972914622</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Lyell Immunopharma, Inc.</name>
        <lei>N/A</lei>
        <title>Lyell Immunopharma, Inc.</title>
        <cusip>55083R104</cusip>
        <identifiers>
          <isin value="US55083R1041"/>
        </identifiers>
        <balance>5151.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>34511.70000000</valUSD>
        <pctVal>0.169560458048</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="18234.71000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>INVESCO PRIVATE PRIME FUND</name>
        <lei>N/A</lei>
        <title>INVESCO PRIVATE PRIME FUND</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="CADIS_ID" value="2487474"/>
        </identifiers>
        <balance>1937500.27000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1937694.06000000</valUSD>
        <pctVal>9.520142223431</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>PF</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="1937694.06000000" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Vertex Pharmaceuticals Inc.</name>
        <lei>54930015RAQRRZ5ZGJ91</lei>
        <title>Vertex Pharmaceuticals Inc.</title>
        <cusip>92532F100</cusip>
        <identifiers>
          <isin value="US92532F1003"/>
        </identifiers>
        <balance>5347.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1506570.72000000</valUSD>
        <pctVal>7.401977340043</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Cogent Biosciences, Inc.</name>
        <lei>N/A</lei>
        <title>Cogent Biosciences, Inc.</title>
        <cusip>19240Q201</cusip>
        <identifiers>
          <isin value="US19240Q2012"/>
        </identifiers>
        <balance>1334.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>21997.66000000</valUSD>
        <pctVal>0.108077356537</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Adicet Bio, Inc.</name>
        <lei>549300VRD2QO80WBOP18</lei>
        <title>Adicet Bio, Inc.</title>
        <cusip>007002108</cusip>
        <identifiers>
          <isin value="US0070021086"/>
        </identifiers>
        <balance>837.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>11851.92000000</valUSD>
        <pctVal>0.058230020078</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Silverback Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Silverback Therapeutics, Inc.</title>
        <cusip>82835W108</cusip>
        <identifiers>
          <isin value="US82835W1080"/>
        </identifiers>
        <balance>735.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3998.40000000</valUSD>
        <pctVal>0.019644657767</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Selecta Biosciences, Inc.</name>
        <lei>529900NMN0LACZOL7C43</lei>
        <title>Selecta Biosciences, Inc.</title>
        <cusip>816212104</cusip>
        <identifiers>
          <isin value="US8162121045"/>
        </identifiers>
        <balance>3180.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5978.40000000</valUSD>
        <pctVal>0.029372654560</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Evelo Biosciences, Inc.</name>
        <lei>N/A</lei>
        <title>Evelo Biosciences, Inc.</title>
        <cusip>299734103</cusip>
        <identifiers>
          <isin value="US2997341035"/>
        </identifiers>
        <balance>2230.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4883.70000000</valUSD>
        <pctVal>0.023994251484</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>REGENXBIO Inc.</name>
        <lei>549300EOES47LATSET33</lei>
        <title>REGENXBIO Inc.</title>
        <cusip>75901B107</cusip>
        <identifiers>
          <isin value="US75901B1070"/>
        </identifiers>
        <balance>905.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>26697.50000000</valUSD>
        <pctVal>0.131168279996</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BioCryst Pharmaceuticals, Inc.</name>
        <lei>549300Z0INP1Z5NP6J59</lei>
        <title>BioCryst Pharmaceuticals, Inc.</title>
        <cusip>09058V103</cusip>
        <identifiers>
          <isin value="US09058V1035"/>
        </identifiers>
        <balance>3905.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>54279.50000000</valUSD>
        <pctVal>0.266682223207</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="53452.95000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Achilles Therapeutics PLC</name>
        <lei>984500FDESEB1BE52A76</lei>
        <title>Achilles Therapeutics PLC, ADR</title>
        <cusip>00449L102</cusip>
        <identifiers>
          <isin value="US00449L1026"/>
        </identifiers>
        <balance>816.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2374.56000000</valUSD>
        <pctVal>0.011666521245</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Clovis Oncology, Inc.</name>
        <lei>529900WCUY9ZAHMRV489</lei>
        <title>Clovis Oncology, Inc.</title>
        <cusip>189464100</cusip>
        <identifiers>
          <isin value="US1894641000"/>
        </identifiers>
        <balance>3006.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3366.72000000</valUSD>
        <pctVal>0.016541132002</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Revance Therapeutics, Inc.</name>
        <lei>549300N33TFDZHS81H11</lei>
        <title>Revance Therapeutics, Inc.</title>
        <cusip>761330109</cusip>
        <identifiers>
          <isin value="US7613301099"/>
        </identifiers>
        <balance>1528.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>30407.20000000</valUSD>
        <pctVal>0.149394517221</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Adverum Biotechnologies, Inc.</name>
        <lei>529900ZEDOOZL1EWHJ89</lei>
        <title>Adverum Biotechnologies, Inc.</title>
        <cusip>00773U108</cusip>
        <identifiers>
          <isin value="US00773U1088"/>
        </identifiers>
        <balance>2062.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2391.92000000</valUSD>
        <pctVal>0.011751813176</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>NRX Pharmaceuticals, Inc.</name>
        <lei>5493003FN4CLS0670T77</lei>
        <title>NRX Pharmaceuticals, Inc.</title>
        <cusip>629444100</cusip>
        <identifiers>
          <isin value="US6294441000"/>
        </identifiers>
        <balance>1398.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>908.70000000</valUSD>
        <pctVal>0.004464560952</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Zentalis Pharmaceuticals, Inc.</name>
        <lei>N/A</lei>
        <title>Zentalis Pharmaceuticals, Inc.</title>
        <cusip>98943L107</cusip>
        <identifiers>
          <isin value="US98943L1070"/>
        </identifiers>
        <balance>1197.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>32091.57000000</valUSD>
        <pctVal>0.157670045483</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Praxis Precision Medicines, Inc.</name>
        <lei>N/A</lei>
        <title>Praxis Precision Medicines, Inc.</title>
        <cusip>74006W108</cusip>
        <identifiers>
          <isin value="US74006W1080"/>
        </identifiers>
        <balance>953.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2973.36000000</valUSD>
        <pctVal>0.014608503305</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Legend Biotech Corp.</name>
        <lei>254900EIUFZTW136H859</lei>
        <title>Legend Biotech Corp., ADR</title>
        <cusip>52490G102</cusip>
        <identifiers>
          <isin value="US52490G1022"/>
        </identifiers>
        <balance>1118.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>51975.82000000</valUSD>
        <pctVal>0.255363944594</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="49150.64000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Xeris Biopharma Holdings, Inc.</name>
        <lei>N/A</lei>
        <title>Xeris Biopharma Holdings, Inc.</title>
        <cusip>98422E103</cusip>
        <identifiers>
          <isin value="US98422E1038"/>
        </identifiers>
        <balance>2836.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4736.12000000</valUSD>
        <pctVal>0.023269171804</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Arrowhead Pharmaceuticals, Inc.</name>
        <lei>549300O3CSB8T7OZ3D66</lei>
        <title>Arrowhead Pharmaceuticals, Inc.</title>
        <cusip>04280A100</cusip>
        <identifiers>
          <isin value="US04280A1007"/>
        </identifiers>
        <balance>2221.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>88195.91000000</valUSD>
        <pctVal>0.433317944281</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Avidity Biosciences, Inc.</name>
        <lei>N/A</lei>
        <title>Avidity Biosciences, Inc.</title>
        <cusip>05370A108</cusip>
        <identifiers>
          <isin value="US05370A1088"/>
        </identifiers>
        <balance>1040.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>20404.80000000</valUSD>
        <pctVal>0.100251428773</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="19684.77000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Verrica Pharmaceuticals Inc.</name>
        <lei>5493002L68H6THU5GW50</lei>
        <title>Verrica Pharmaceuticals Inc.</title>
        <cusip>92511W108</cusip>
        <identifiers>
          <isin value="US92511W1080"/>
        </identifiers>
        <balance>808.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3167.36000000</valUSD>
        <pctVal>0.015561650466</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Immunovant, Inc.</name>
        <lei>N/A</lei>
        <title>Immunovant, Inc.</title>
        <cusip>45258J102</cusip>
        <identifiers>
          <isin value="US45258J1025"/>
        </identifiers>
        <balance>2438.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>12555.70000000</valUSD>
        <pctVal>0.061687782494</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Karuna Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Karuna Therapeutics, Inc.</title>
        <cusip>48576A100</cusip>
        <identifiers>
          <isin value="US48576A1007"/>
        </identifiers>
        <balance>627.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>159922.62000000</valUSD>
        <pctVal>0.785720573011</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Amphastar Pharmaceuticals, Inc.</name>
        <lei>54930055TH0ZLSAQMJ38</lei>
        <title>Amphastar Pharmaceuticals, Inc.</title>
        <cusip>03209R103</cusip>
        <identifiers>
          <isin value="US03209R1032"/>
        </identifiers>
        <balance>1025.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>30340.00000000</valUSD>
        <pctVal>0.149064354905</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Bolt Biotherapeutics, Inc.</name>
        <lei>254900W0P77PQ6B8OY50</lei>
        <title>Bolt Biotherapeutics, Inc.</title>
        <cusip>097702104</cusip>
        <identifiers>
          <isin value="US0977021049"/>
        </identifiers>
        <balance>812.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1461.60000000</valUSD>
        <pctVal>0.007181030360</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Codiak Biosciences, Inc.</name>
        <lei>549300QVVVW74Y10Q230</lei>
        <title>Codiak Biosciences, Inc.</title>
        <cusip>192010106</cusip>
        <identifiers>
          <isin value="US1920101060"/>
        </identifiers>
        <balance>498.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1070.70000000</valUSD>
        <pctVal>0.005260487963</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Relmada Therapeutics, Inc.</name>
        <lei>549300217EASRZ9JSF81</lei>
        <title>Relmada Therapeutics, Inc.</title>
        <cusip>75955J402</cusip>
        <identifiers>
          <isin value="US75955J4022"/>
        </identifiers>
        <balance>627.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>18270.78000000</valUSD>
        <pctVal>0.089766711744</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="11376.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Rubius Therapeutics, Inc.</name>
        <lei>549300ER84PB0QV6HZ76</lei>
        <title>Rubius Therapeutics, Inc.</title>
        <cusip>78116T103</cusip>
        <identifiers>
          <isin value="US78116T1034"/>
        </identifiers>
        <balance>1887.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1320.90000000</valUSD>
        <pctVal>0.006489753012</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Vir Biotechnology, Inc.</name>
        <lei>N/A</lei>
        <title>Vir Biotechnology, Inc.</title>
        <cusip>92764N102</cusip>
        <identifiers>
          <isin value="US92764N1028"/>
        </identifiers>
        <balance>2785.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>66143.75000000</valUSD>
        <pctVal>0.324972822175</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ovid Therapeutics Inc.</name>
        <lei>549300H36NUI4L6U8F17</lei>
        <title>Ovid Therapeutics Inc.</title>
        <cusip>690469101</cusip>
        <identifiers>
          <isin value="US6904691010"/>
        </identifiers>
        <balance>1474.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2962.74000000</valUSD>
        <pctVal>0.014556325868</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Akero Therapeutics, Inc.</name>
        <lei>549300SI3KG74LBE2955</lei>
        <title>Akero Therapeutics, Inc.</title>
        <cusip>00973Y108</cusip>
        <identifiers>
          <isin value="US00973Y1082"/>
        </identifiers>
        <balance>733.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>8612.75000000</valUSD>
        <pctVal>0.042315557769</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="8961.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Viatris Inc.</name>
        <lei>254900ZZTSW7NL773X71</lei>
        <title>Viatris Inc.</title>
        <cusip>92556V106</cusip>
        <identifiers>
          <isin value="US92556V1061"/>
        </identifiers>
        <balance>25446.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>243009.30000000</valUSD>
        <pctVal>1.193936207667</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Maravai LifeSciences Holdings, Inc.</name>
        <lei>N/A</lei>
        <title>Maravai LifeSciences Holdings, Inc.</title>
        <cusip>56600D107</cusip>
        <identifiers>
          <isin value="US56600D1072"/>
        </identifiers>
        <balance>2761.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>57622.07000000</valUSD>
        <pctVal>0.283104703127</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Intellia Therapeutics, Inc.</name>
        <lei>5493002T5BCPE5DZC723</lei>
        <title>Intellia Therapeutics, Inc.</title>
        <cusip>45826J105</cusip>
        <identifiers>
          <isin value="US45826J1051"/>
        </identifiers>
        <balance>1595.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>95795.70000000</valUSD>
        <pctVal>0.470656698195</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Supernus Pharmaceuticals, Inc.</name>
        <lei>549300GRM36VBKISYJ58</lei>
        <title>Supernus Pharmaceuticals, Inc.</title>
        <cusip>868459108</cusip>
        <identifiers>
          <isin value="US8684591089"/>
        </identifiers>
        <balance>1121.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>38371.83000000</valUSD>
        <pctVal>0.188525777373</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ImmunoGen, Inc.</name>
        <lei>54930084U0R1OP766Y02</lei>
        <title>ImmunoGen, Inc.</title>
        <cusip>45253H101</cusip>
        <identifiers>
          <isin value="US45253H1014"/>
        </identifiers>
        <balance>4614.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>26807.34000000</valUSD>
        <pctVal>0.131707938162</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>I-Mab</name>
        <lei>549300L1A5T19703RR64</lei>
        <title>I-Mab, ADR</title>
        <cusip>44975P103</cusip>
        <identifiers>
          <isin value="US44975P1030"/>
        </identifiers>
        <balance>1084.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6644.92000000</valUSD>
        <pctVal>0.032647353764</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Acumen Pharmaceuticals, Inc.</name>
        <lei>N/A</lei>
        <title>Acumen Pharmaceuticals, Inc.</title>
        <cusip>00509G209</cusip>
        <identifiers>
          <isin value="US00509G2093"/>
        </identifiers>
        <balance>848.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4825.12000000</valUSD>
        <pctVal>0.023706440347</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Paratek Pharmaceuticals, Inc.</name>
        <lei>5493007V5QDIWECEYV79</lei>
        <title>Paratek Pharmaceuticals, Inc.</title>
        <cusip>699374302</cusip>
        <identifiers>
          <isin value="US6993743029"/>
        </identifiers>
        <balance>1138.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2856.38000000</valUSD>
        <pctVal>0.014033765394</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Mersana Therapeutics, Inc.</name>
        <lei>529900VWD5VDZ7PVOS22</lei>
        <title>Mersana Therapeutics, Inc.</title>
        <cusip>59045L106</cusip>
        <identifiers>
          <isin value="US59045L1061"/>
        </identifiers>
        <balance>2034.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>15255.00000000</valUSD>
        <pctVal>0.074949793476</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BioAtla, Inc.</name>
        <lei>N/A</lei>
        <title>BioAtla, Inc.</title>
        <cusip>09077B104</cusip>
        <identifiers>
          <isin value="US09077B1044"/>
        </identifiers>
        <balance>754.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6567.34000000</valUSD>
        <pctVal>0.032266193162</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Precigen, Inc.</name>
        <lei>549300XCWNQU35K64G19</lei>
        <title>Precigen, Inc.</title>
        <cusip>74017N105</cusip>
        <identifiers>
          <isin value="US74017N1054"/>
        </identifiers>
        <balance>4373.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>9664.33000000</valUSD>
        <pctVal>0.047482106692</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>EyePoint Pharmaceuticals, Inc.</name>
        <lei>549300QE1RU34T50MR69</lei>
        <title>EyePoint Pharmaceuticals, Inc.</title>
        <cusip>30233G209</cusip>
        <identifiers>
          <isin value="US30233G2093"/>
        </identifiers>
        <balance>709.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7090.00000000</valUSD>
        <pctVal>0.034834089528</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Aurinia Pharmaceuticals Inc.</name>
        <lei>5299008YP2BW4570ML28</lei>
        <title>Aurinia Pharmaceuticals Inc.</title>
        <cusip>05156V102</cusip>
        <identifiers>
          <isin value="CA05156V1022"/>
        </identifiers>
        <balance>2969.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>21851.84000000</valUSD>
        <pctVal>0.107360923965</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Scholar Rock Holding Corp.</name>
        <lei>549300Z1FLPGL4OWJ459</lei>
        <title>Scholar Rock Holding Corp.</title>
        <cusip>80706P103</cusip>
        <identifiers>
          <isin value="US80706P1030"/>
        </identifiers>
        <balance>1088.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>9073.92000000</valUSD>
        <pctVal>0.044581345789</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Altimmune, Inc.</name>
        <lei>549300EOYCQ8SW3NVE64</lei>
        <title>Altimmune, Inc.</title>
        <cusip>02155H200</cusip>
        <identifiers>
          <isin value="US02155H2004"/>
        </identifiers>
        <balance>1026.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>22654.08000000</valUSD>
        <pctVal>0.111302433130</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Adaptimmune Therapeutics PLC</name>
        <lei>549300UUNWK8TRT5EW12</lei>
        <title>Adaptimmune Therapeutics PLC, ADR</title>
        <cusip>00653A107</cusip>
        <identifiers>
          <isin value="US00653A1079"/>
        </identifiers>
        <balance>2909.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5759.82000000</valUSD>
        <pctVal>0.028298742672</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Harrow Health, Inc.</name>
        <lei>N/A</lei>
        <title>Harrow Health, Inc.</title>
        <cusip>415858109</cusip>
        <identifiers>
          <isin value="US4158581094"/>
        </identifiers>
        <balance>576.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5178.24000000</valUSD>
        <pctVal>0.025441364704</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="4947.60000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Provention Bio, Inc.</name>
        <lei>5493003LM26XAVJKLD34</lei>
        <title>Provention Bio, Inc.</title>
        <cusip>74374N102</cusip>
        <identifiers>
          <isin value="US74374N1028"/>
        </identifiers>
        <balance>1705.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7365.60000000</valUSD>
        <pctVal>0.036188148071</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Protagonist Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Protagonist Therapeutics, Inc.</title>
        <cusip>74366E102</cusip>
        <identifiers>
          <isin value="US74366E1029"/>
        </identifiers>
        <balance>1014.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>8842.08000000</valUSD>
        <pctVal>0.043442285801</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PMV Pharmaceuticals, Inc.</name>
        <lei>N/A</lei>
        <title>PMV Pharmaceuticals, Inc.</title>
        <cusip>69353Y103</cusip>
        <identifiers>
          <isin value="US69353Y1038"/>
        </identifiers>
        <balance>955.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>13293.60000000</valUSD>
        <pctVal>0.065313180895</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="7395.08000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ImmunityBio Inc.</name>
        <lei>529900J9XLBR4HFL4B83</lei>
        <title>ImmunityBio Inc.</title>
        <cusip>45256X103</cusip>
        <identifiers>
          <isin value="US45256X1037"/>
        </identifiers>
        <balance>8332.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>33328.00000000</valUSD>
        <pctVal>0.163744786430</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="31672.32000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alaunos Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Alaunos Therapeutics, Inc.</title>
        <cusip>98973P101</cusip>
        <identifiers>
          <isin value="US98973P1012"/>
        </identifiers>
        <balance>4519.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>11116.74000000</valUSD>
        <pctVal>0.054617985390</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Travere Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Travere Therapeutics, Inc.</title>
        <cusip>89422G107</cusip>
        <identifiers>
          <isin value="US89422G1076"/>
        </identifiers>
        <balance>1334.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>35697.84000000</valUSD>
        <pctVal>0.175388117703</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BridgeBio Pharma, Inc.</name>
        <lei>54930028YG89VTY2J114</lei>
        <title>BridgeBio Pharma, Inc.</title>
        <cusip>10806X102</cusip>
        <identifiers>
          <isin value="US10806X1028"/>
        </identifiers>
        <balance>3102.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>32571.00000000</valUSD>
        <pctVal>0.160025547252</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="30554.70000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Cellectis</name>
        <lei>5493000KKX5VQ37Q2W83</lei>
        <title>Cellectis, ADR</title>
        <cusip>15117K103</cusip>
        <identifiers>
          <isin value="US15117K1034"/>
        </identifiers>
        <balance>387.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1280.97000000</valUSD>
        <pctVal>0.006293571743</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>FR</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Surface Oncology, Inc.</name>
        <lei>549300FCSG6MNIMFH738</lei>
        <title>Surface Oncology, Inc.</title>
        <cusip>86877M209</cusip>
        <identifiers>
          <isin value="US86877M2098"/>
        </identifiers>
        <balance>1141.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1551.76000000</valUSD>
        <pctVal>0.007623998133</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Singular Genomics Systems, Inc.</name>
        <lei>N/A</lei>
        <title>Singular Genomics Systems, Inc.</title>
        <cusip>82933R100</cusip>
        <identifiers>
          <isin value="US82933R1005"/>
        </identifiers>
        <balance>1478.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3946.26000000</valUSD>
        <pctVal>0.019388487184</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3187.84000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BeiGene, Ltd.</name>
        <lei>549300JFUK6FRD5MH739</lei>
        <title>BeiGene, Ltd., ADR</title>
        <cusip>07725L102</cusip>
        <identifiers>
          <isin value="US07725L1026"/>
        </identifiers>
        <balance>1031.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>176981.46000000</valUSD>
        <pctVal>0.869532866354</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="168840.60000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Cyteir Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Cyteir Therapeutics, Inc.</title>
        <cusip>23284P103</cusip>
        <identifiers>
          <isin value="US23284P1030"/>
        </identifiers>
        <balance>742.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1602.72000000</valUSD>
        <pctVal>0.007874371222</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>RedHill Biopharma Ltd.</name>
        <lei>52990034U7FZBKRAOE32</lei>
        <title>RedHill Biopharma Ltd., ADR</title>
        <cusip>757468103</cusip>
        <identifiers>
          <isin value="US7574681034"/>
        </identifiers>
        <balance>1076.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>967.65000000</valUSD>
        <pctVal>0.004754189948</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IL</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="985.13000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>G1 Therapeutics, Inc.</name>
        <lei>529900TC35UPZQYRKW13</lei>
        <title>G1 Therapeutics, Inc.</title>
        <cusip>3621LQ109</cusip>
        <identifiers>
          <isin value="US3621LQ1099"/>
        </identifiers>
        <balance>902.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>13088.02000000</valUSD>
        <pctVal>0.064303139693</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="12398.80000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AVROBIO, Inc.</name>
        <lei>N/A</lei>
        <title>AVROBIO, Inc.</title>
        <cusip>05455M100</cusip>
        <identifiers>
          <isin value="US05455M1009"/>
        </identifiers>
        <balance>910.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>864.50000000</valUSD>
        <pctVal>0.004247400620</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>RAPT Therapeutics, Inc.</name>
        <lei>549300MB473BIU78ES48</lei>
        <title>RAPT Therapeutics, Inc.</title>
        <cusip>75382E109</cusip>
        <identifiers>
          <isin value="US75382E1091"/>
        </identifiers>
        <balance>619.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>16533.49000000</valUSD>
        <pctVal>0.081231180658</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Adaptive Biotechnologies Corp.</name>
        <lei>549300ZTF7OT1FW66Q96</lei>
        <title>Adaptive Biotechnologies Corp.</title>
        <cusip>00650F109</cusip>
        <identifiers>
          <isin value="US00650F1093"/>
        </identifiers>
        <balance>2981.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>26590.52000000</valUSD>
        <pctVal>0.130642673382</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Rocket Pharmaceuticals, Inc.</name>
        <lei>549300R7VV82YUIN4Y93</lei>
        <title>Rocket Pharmaceuticals, Inc.</title>
        <cusip>77313F106</cusip>
        <identifiers>
          <isin value="US77313F1066"/>
        </identifiers>
        <balance>1379.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>21250.39000000</valUSD>
        <pctVal>0.104405922111</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="20939.10000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Larimar Therapeutics, Inc.</name>
        <lei>529900NCBZHTTJV6HX73</lei>
        <title>Larimar Therapeutics, Inc.</title>
        <cusip>517125100</cusip>
        <identifiers>
          <isin value="US5171251003"/>
        </identifiers>
        <balance>343.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>932.96000000</valUSD>
        <pctVal>0.004583753479</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Amgen Inc.</name>
        <lei>62QBXGPJ34PQ72Z12S66</lei>
        <title>Amgen Inc.</title>
        <cusip>031162100</cusip>
        <identifiers>
          <isin value="US0311621009"/>
        </identifiers>
        <balance>6104.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1466791.20000000</valUSD>
        <pctVal>7.206535399131</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Infinity Pharmaceuticals, Inc.</name>
        <lei>529900A03D1G15M8WM72</lei>
        <title>Infinity Pharmaceuticals, Inc.</title>
        <cusip>45665G303</cusip>
        <identifiers>
          <isin value="US45665G3039"/>
        </identifiers>
        <balance>1862.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2997.82000000</valUSD>
        <pctVal>0.014728678458</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Brooklyn Immunotherapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Brooklyn Immunotherapeutics, Inc.</title>
        <cusip>114082100</cusip>
        <identifiers>
          <isin value="US1140821000"/>
        </identifiers>
        <balance>1229.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>505.73000000</valUSD>
        <pctVal>0.002484717079</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Gamida Cell Ltd.</name>
        <lei>N/A</lei>
        <title>Gamida Cell Ltd.</title>
        <cusip>M47364100</cusip>
        <identifiers>
          <isin value="IL0011552663"/>
        </identifiers>
        <balance>1254.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3323.10000000</valUSD>
        <pctVal>0.016326821285</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IL</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>C4 Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>C4 Therapeutics, Inc.</title>
        <cusip>12529R107</cusip>
        <identifiers>
          <isin value="US12529R1077"/>
        </identifiers>
        <balance>1017.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>10251.36000000</valUSD>
        <pctVal>0.050366261216</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Cara Therapeutics, Inc.</name>
        <lei>549300COVOY41P0GZ881</lei>
        <title>Cara Therapeutics, Inc.</title>
        <cusip>140755109</cusip>
        <identifiers>
          <isin value="US1407551092"/>
        </identifiers>
        <balance>1117.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>11527.44000000</valUSD>
        <pctVal>0.056635807755</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Neoleukin Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Neoleukin Therapeutics, Inc.</title>
        <cusip>64049K104</cusip>
        <identifiers>
          <isin value="US64049K1043"/>
        </identifiers>
        <balance>917.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>944.51000000</valUSD>
        <pctVal>0.004640500126</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Athenex, Inc.</name>
        <lei>5493001V4L0Q5EPPOH52</lei>
        <title>Athenex, Inc.</title>
        <cusip>04685N103</cusip>
        <identifiers>
          <isin value="US04685N1037"/>
        </identifiers>
        <balance>2344.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1123.95000000</valUSD>
        <pctVal>0.005522112119</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Affimed N.V.</name>
        <lei>5493004V4FSXT1D04610</lei>
        <title>Affimed N.V.</title>
        <cusip>N01045108</cusip>
        <identifiers>
          <isin value="NL0010872420"/>
        </identifiers>
        <balance>3121.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>8177.02000000</valUSD>
        <pctVal>0.040174759767</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Halozyme Therapeutics, Inc.</name>
        <lei>529900242I3SV9AGM753</lei>
        <title>Halozyme Therapeutics, Inc.</title>
        <cusip>40637H109</cusip>
        <identifiers>
          <isin value="US40637H1095"/>
        </identifiers>
        <balance>2893.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>117831.89000000</valUSD>
        <pctVal>0.578923357620</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Candel Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Candel Therapeutics, Inc.</title>
        <cusip>137404109</cusip>
        <identifiers>
          <isin value="US1374041093"/>
        </identifiers>
        <balance>596.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2068.12000000</valUSD>
        <pctVal>0.010160941782</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Global Blood Therapeutics, Inc.</name>
        <lei>549300U4G0QKK99GRT15</lei>
        <title>Global Blood Therapeutics, Inc.</title>
        <cusip>37890U108</cusip>
        <identifiers>
          <isin value="US37890U1088"/>
        </identifiers>
        <balance>1370.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>93023.00000000</valUSD>
        <pctVal>0.457034063494</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SIGA Technologies, Inc.</name>
        <lei>N/A</lei>
        <title>SIGA Technologies, Inc.</title>
        <cusip>826917106</cusip>
        <identifiers>
          <isin value="US8269171067"/>
        </identifiers>
        <balance>1521.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>22936.68000000</valUSD>
        <pctVal>0.112690883582</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="23262.75000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kronos Bio, Inc.</name>
        <lei>N/A</lei>
        <title>Kronos Bio, Inc.</title>
        <cusip>50107A104</cusip>
        <identifiers>
          <isin value="US50107A1043"/>
        </identifiers>
        <balance>1191.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4764.00000000</valUSD>
        <pctVal>0.023406149860</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3857.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Morphic Holding, Inc.</name>
        <lei>549300RWWOUFLHTY1224</lei>
        <title>Morphic Holding, Inc.</title>
        <cusip>61775R105</cusip>
        <identifiers>
          <isin value="US61775R1059"/>
        </identifiers>
        <balance>803.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>22098.56000000</valUSD>
        <pctVal>0.108573091323</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="16448.54000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Jounce Therapeutics, Inc.</name>
        <lei>5493004MZJQIV2K8ZT61</lei>
        <title>Jounce Therapeutics, Inc.</title>
        <cusip>481116101</cusip>
        <identifiers>
          <isin value="US4811161011"/>
        </identifiers>
        <balance>1085.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3971.10000000</valUSD>
        <pctVal>0.019510529326</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>IGM Biosciences, Inc.</name>
        <lei>5493008XCQES2N0VY969</lei>
        <title>IGM Biosciences, Inc.</title>
        <cusip>449585108</cusip>
        <identifiers>
          <isin value="US4495851085"/>
        </identifiers>
        <balance>575.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>11160.75000000</valUSD>
        <pctVal>0.054834212228</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Allakos Inc.</name>
        <lei>549300S6ZD1W6BPMDY37</lei>
        <title>Allakos Inc.</title>
        <cusip>01671P100</cusip>
        <identifiers>
          <isin value="US01671P1003"/>
        </identifiers>
        <balance>1145.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5553.25000000</valUSD>
        <pctVal>0.027283837471</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kamada Ltd.</name>
        <lei>N/A</lei>
        <title>Kamada Ltd.</title>
        <cusip>M6240T109</cusip>
        <identifiers>
          <isin value="IL0010941198"/>
        </identifiers>
        <balance>936.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4670.64000000</valUSD>
        <pctVal>0.022947460072</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IL</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>KalVista Pharmaceuticals, Inc.</name>
        <lei>529900Q7IDA3WUGRZA51</lei>
        <title>KalVista Pharmaceuticals, Inc.</title>
        <cusip>483497103</cusip>
        <identifiers>
          <isin value="US4834971032"/>
        </identifiers>
        <balance>512.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>8432.64000000</valUSD>
        <pctVal>0.041430653980</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Krystal Biotech, Inc.</name>
        <lei>549300YONUY68210OE41</lei>
        <title>Krystal Biotech, Inc.</title>
        <cusip>501147102</cusip>
        <identifiers>
          <isin value="US5011471027"/>
        </identifiers>
        <balance>538.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>37719.18000000</valUSD>
        <pctVal>0.185319223278</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Talaris Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Talaris Therapeutics, Inc.</title>
        <cusip>87410C104</cusip>
        <identifiers>
          <isin value="US87410C1045"/>
        </identifiers>
        <balance>871.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2883.01000000</valUSD>
        <pctVal>0.014164602038</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Prelude Therapeutics Inc.</name>
        <lei>N/A</lei>
        <title>Prelude Therapeutics Inc.</title>
        <cusip>74065P101</cusip>
        <identifiers>
          <isin value="US74065P1012"/>
        </identifiers>
        <balance>1010.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7272.00000000</valUSD>
        <pctVal>0.035728279132</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="7112.88000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Applied Molecular Transport Inc.</name>
        <lei>N/A</lei>
        <title>Applied Molecular Transport Inc.</title>
        <cusip>03824M109</cusip>
        <identifiers>
          <isin value="US03824M1099"/>
        </identifiers>
        <balance>805.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1191.40000000</valUSD>
        <pctVal>0.005853502717</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Monte Rosa Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Monte Rosa Therapeutics, Inc.</title>
        <cusip>61225M102</cusip>
        <identifiers>
          <isin value="US61225M1027"/>
        </identifiers>
        <balance>981.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7769.52000000</valUSD>
        <pctVal>0.038172659417</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="7680.61000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Innoviva, Inc.</name>
        <lei>549300ACOX4QTBES6535</lei>
        <title>Innoviva, Inc.</title>
        <cusip>45781M101</cusip>
        <identifiers>
          <isin value="US45781M1018"/>
        </identifiers>
        <balance>1457.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>19174.12000000</valUSD>
        <pctVal>0.094204938321</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Personalis, Inc.</name>
        <lei>549300EZ2NYFK7H0US48</lei>
        <title>Personalis, Inc.</title>
        <cusip>71535D106</cusip>
        <identifiers>
          <isin value="US71535D1063"/>
        </identifiers>
        <balance>952.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3151.12000000</valUSD>
        <pctVal>0.015481861240</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Relay Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Relay Therapeutics, Inc.</title>
        <cusip>75943R102</cusip>
        <identifiers>
          <isin value="US75943R1023"/>
        </identifiers>
        <balance>2279.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>52348.63000000</valUSD>
        <pctVal>0.257195608475</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="8929.58000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Rani Therapeutics Holdings, Inc.</name>
        <lei>N/A</lei>
        <title>Rani Therapeutics Holdings, Inc.</title>
        <cusip>753018100</cusip>
        <identifiers>
          <isin value="US7530181004"/>
        </identifiers>
        <balance>511.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4547.90000000</valUSD>
        <pctVal>0.022344422533</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Fulcrum Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Fulcrum Therapeutics, Inc.</title>
        <cusip>359616109</cusip>
        <identifiers>
          <isin value="US3596161097"/>
        </identifiers>
        <balance>1092.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>8080.80000000</valUSD>
        <pctVal>0.039702018428</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="6097.12000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Regeneron Pharmaceuticals, Inc.</name>
        <lei>549300RCBFWIRX3HYQ56</lei>
        <title>Regeneron Pharmaceuticals, Inc.</title>
        <cusip>75886F107</cusip>
        <identifiers>
          <isin value="US75886F1075"/>
        </identifiers>
        <balance>2259.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1312614.54000000</valUSD>
        <pctVal>6.449045472814</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Gracell Biotechnologies Inc.</name>
        <lei>N/A</lei>
        <title>Gracell Biotechnologies Inc., ADR</title>
        <cusip>38406L103</cusip>
        <identifiers>
          <isin value="US38406L1035"/>
        </identifiers>
        <balance>1351.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3391.01000000</valUSD>
        <pctVal>0.016660471922</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CRISPR Therapeutics AG</name>
        <lei>506700O6IRRIQLT3W370</lei>
        <title>CRISPR Therapeutics AG</title>
        <cusip>H17182108</cusip>
        <identifiers>
          <isin value="CH0334081137"/>
        </identifiers>
        <balance>1631.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>106161.79000000</valUSD>
        <pctVal>0.521586642781</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CH</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="83873.79000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Gilead Sciences, Inc.</name>
        <lei>549300WTZWR07K8MNV44</lei>
        <title>Gilead Sciences, Inc.</title>
        <cusip>375558103</cusip>
        <identifiers>
          <isin value="US3755581036"/>
        </identifiers>
        <balance>24169.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1534006.43000000</valUSD>
        <pctVal>7.536772541511</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sana Biotechnology, Inc.</name>
        <lei>N/A</lei>
        <title>Sana Biotechnology, Inc.</title>
        <cusip>799566104</cusip>
        <identifiers>
          <isin value="US7995661045"/>
        </identifiers>
        <balance>3966.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>27008.46000000</valUSD>
        <pctVal>0.132696066806</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="26068.64000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>iTeos Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>iTeos Therapeutics, Inc.</title>
        <cusip>46565G104</cusip>
        <identifiers>
          <isin value="US46565G1040"/>
        </identifiers>
        <balance>745.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>16524.10000000</valUSD>
        <pctVal>0.081185046371</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Guardant Health, Inc.</name>
        <lei>254900M8C3E5VC8BR186</lei>
        <title>Guardant Health, Inc.</title>
        <cusip>40131M109</cusip>
        <identifiers>
          <isin value="US40131M1099"/>
        </identifiers>
        <balance>2144.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>107328.64000000</valUSD>
        <pctVal>0.527319528165</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Puma Biotechnology, Inc.</name>
        <lei>N/A</lei>
        <title>Puma Biotechnology, Inc.</title>
        <cusip>74587V107</cusip>
        <identifiers>
          <isin value="US74587V1070"/>
        </identifiers>
        <balance>941.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2521.88000000</valUSD>
        <pctVal>0.012390323511</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Omeros Corp.</name>
        <lei>549300CJWLXX2MXVVV71</lei>
        <title>Omeros Corp.</title>
        <cusip>682143102</cusip>
        <identifiers>
          <isin value="US6821431029"/>
        </identifiers>
        <balance>1305.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5259.15000000</valUSD>
        <pctVal>0.025838886028</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Seagen Inc.</name>
        <lei>N/A</lei>
        <title>Seagen Inc.</title>
        <cusip>81181C104</cusip>
        <identifiers>
          <isin value="US81181C1045"/>
        </identifiers>
        <balance>3862.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>595867.98000000</valUSD>
        <pctVal>2.927576666044</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Apellis Pharmaceuticals, Inc.</name>
        <lei>254900HS0ZFRXXSB9D42</lei>
        <title>Apellis Pharmaceuticals, Inc.</title>
        <cusip>03753U106</cusip>
        <identifiers>
          <isin value="US03753U1060"/>
        </identifiers>
        <balance>2239.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>135481.89000000</valUSD>
        <pctVal>0.665640096713</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="130389.44000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Incyte Corp.</name>
        <lei>549300Z4WN6JVZ3T4680</lei>
        <title>Incyte Corp.</title>
        <cusip>45337C102</cusip>
        <identifiers>
          <isin value="US45337C1027"/>
        </identifiers>
        <balance>4652.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>327640.36000000</valUSD>
        <pctVal>1.609739581560</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="322165.80000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Nautilus Biotechnology, Inc.</name>
        <lei>N/A</lei>
        <title>Nautilus Biotechnology, Inc.</title>
        <cusip>63909J108</cusip>
        <identifiers>
          <isin value="US63909J1088"/>
        </identifiers>
        <balance>2602.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5750.42000000</valUSD>
        <pctVal>0.028252559253</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="4380.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Gossamer Bio, Inc.</name>
        <lei>549300ZOC0N2W6PSFR58</lei>
        <title>Gossamer Bio, Inc.</title>
        <cusip>38341P102</cusip>
        <identifiers>
          <isin value="US38341P1021"/>
        </identifiers>
        <balance>1962.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>27369.90000000</valUSD>
        <pctVal>0.134471868402</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="25456.48000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CytomX Therapeutics, Inc.</name>
        <lei>5493004VW2FW0QLL3345</lei>
        <title>CytomX Therapeutics, Inc.</title>
        <cusip>23284F105</cusip>
        <identifiers>
          <isin value="US23284F1057"/>
        </identifiers>
        <balance>1369.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2053.50000000</valUSD>
        <pctVal>0.010089111825</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Y-mAbs Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Y-mAbs Therapeutics, Inc.</title>
        <cusip>984241109</cusip>
        <identifiers>
          <isin value="US9842411095"/>
        </identifiers>
        <balance>911.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14648.88000000</valUSD>
        <pctVal>0.071971847306</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="14010.55000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Grifols, S.A.</name>
        <lei>959800HSSNXWRKBK4N60</lei>
        <title>Grifols, S.A., ADR</title>
        <cusip>398438408</cusip>
        <identifiers>
          <isin value="US3984384087"/>
        </identifiers>
        <balance>2417.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>18780.09000000</valUSD>
        <pctVal>0.092269017828</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>ES</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Denali Therapeutics Inc.</name>
        <lei>549300ZTQ2HO18L3Q830</lei>
        <title>Denali Therapeutics Inc.</title>
        <cusip>24823R105</cusip>
        <identifiers>
          <isin value="US24823R1059"/>
        </identifiers>
        <balance>2580.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>71388.60000000</valUSD>
        <pctVal>0.350741450449</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AC Immune S.A.</name>
        <lei>967600VLQ0ZC2HSOG765</lei>
        <title>AC Immune S.A.</title>
        <cusip>H00263105</cusip>
        <identifiers>
          <isin value="CH0329023102"/>
        </identifiers>
        <balance>1722.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5200.44000000</valUSD>
        <pctVal>0.025550436184</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CH</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Icosavax, Inc.</name>
        <lei>N/A</lei>
        <title>Icosavax, Inc.</title>
        <cusip>45114M109</cusip>
        <identifiers>
          <isin value="US45114M1099"/>
        </identifiers>
        <balance>830.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3917.60000000</valUSD>
        <pctVal>0.019247676887</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sanofi</name>
        <lei>549300E9PC51EN656011</lei>
        <title>Sanofi, ADR</title>
        <cusip>80105N105</cusip>
        <identifiers>
          <isin value="US80105N1054"/>
        </identifiers>
        <balance>5973.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>245072.19000000</valUSD>
        <pctVal>1.204071453781</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>FR</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AbCellera Biologics Inc.</name>
        <lei>9845000861BC95FF9F73</lei>
        <title>AbCellera Biologics Inc.</title>
        <cusip>00288U106</cusip>
        <identifiers>
          <isin value="CA00288U1066"/>
        </identifiers>
        <balance>5975.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>63813.00000000</valUSD>
        <pctVal>0.313521545142</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CureVac N.V.</name>
        <lei>724500BUT8GAG9LMYN56</lei>
        <title>CureVac N.V.</title>
        <cusip>N2451R105</cusip>
        <identifiers>
          <isin value="NL0015436031"/>
        </identifiers>
        <balance>3936.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>38730.24000000</valUSD>
        <pctVal>0.190286692186</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="39895.04000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BioNTech SE</name>
        <lei>894500UZJ5LG1F8J1U58</lei>
        <title>BioNTech SE, ADR</title>
        <cusip>09075V102</cusip>
        <identifiers>
          <isin value="US09075V1026"/>
        </identifiers>
        <balance>1846.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>267005.44000000</valUSD>
        <pctVal>1.311832355635</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>DE</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>NGM Biopharmaceuticals, Inc.</name>
        <lei>5493008V5DSDZIGQOP17</lei>
        <title>NGM Biopharmaceuticals, Inc.</title>
        <cusip>62921N105</cusip>
        <identifiers>
          <isin value="US62921N1054"/>
        </identifiers>
        <balance>1656.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>23366.16000000</valUSD>
        <pctVal>0.114800974523</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>KemPharm, Inc.</name>
        <lei>254900CU6T74V18Y1W18</lei>
        <title>KemPharm, Inc.</title>
        <cusip>488445206</cusip>
        <identifiers>
          <isin value="US4884452065"/>
        </identifiers>
        <balance>718.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3920.28000000</valUSD>
        <pctVal>0.019260844075</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3805.60000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Connect Biopharma Holdings Ltd.</name>
        <lei>N/A</lei>
        <title>Connect Biopharma Holdings Ltd., ADR</title>
        <cusip>207523101</cusip>
        <identifiers>
          <isin value="US2075231017"/>
        </identifiers>
        <balance>985.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1379.00000000</valUSD>
        <pctVal>0.006775205847</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Arbutus Biopharma Corp.</name>
        <lei>25490064CESONAUIAS23</lei>
        <title>Arbutus Biopharma Corp.</title>
        <cusip>03879J100</cusip>
        <identifiers>
          <isin value="CA03879J1003"/>
        </identifiers>
        <balance>3086.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6850.92000000</valUSD>
        <pctVal>0.033659458480</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Chinook Therapeutics, Inc.</name>
        <lei>549300X0O3003W5QYQ48</lei>
        <title>Chinook Therapeutics, Inc.</title>
        <cusip>16961L106</cusip>
        <identifiers>
          <isin value="US16961L1061"/>
        </identifiers>
        <balance>1293.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>26894.40000000</valUSD>
        <pctVal>0.132135675233</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Nkarta, Inc.</name>
        <lei>N/A</lei>
        <title>Nkarta, Inc.</title>
        <cusip>65487U108</cusip>
        <identifiers>
          <isin value="US65487U1088"/>
        </identifiers>
        <balance>1013.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14577.07000000</valUSD>
        <pctVal>0.071619035463</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Impel Pharmaceuticals Inc.</name>
        <lei>549300OM070Y5YFLMR84</lei>
        <title>Impel Pharmaceuticals Inc.</title>
        <cusip>45258K109</cusip>
        <identifiers>
          <isin value="US45258K1097"/>
        </identifiers>
        <balance>486.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3800.52000000</valUSD>
        <pctVal>0.018672447663</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Harmony Biosciences Holdings, Inc.</name>
        <lei>N/A</lei>
        <title>Harmony Biosciences Holdings, Inc.</title>
        <cusip>413197104</cusip>
        <identifiers>
          <isin value="US4131971040"/>
        </identifiers>
        <balance>1239.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>54404.49000000</valUSD>
        <pctVal>0.267296315287</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="32729.97000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ocular Therapeutix, Inc.</name>
        <lei>529900ABAWFXOHSIHG03</lei>
        <title>Ocular Therapeutix, Inc.</title>
        <cusip>67576A100</cusip>
        <identifiers>
          <isin value="US67576A1007"/>
        </identifiers>
        <balance>1610.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>8178.80000000</valUSD>
        <pctVal>0.040183505138</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Erasca, Inc.</name>
        <lei>N/A</lei>
        <title>Erasca, Inc.</title>
        <cusip>29479A108</cusip>
        <identifiers>
          <isin value="US29479A1088"/>
        </identifiers>
        <balance>2554.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>23037.08000000</valUSD>
        <pctVal>0.113184161803</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="20830.72000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Homology Medicines, Inc.</name>
        <lei>549300RWKPJEFTM3K452</lei>
        <title>Homology Medicines, Inc.</title>
        <cusip>438083107</cusip>
        <identifiers>
          <isin value="US4380831077"/>
        </identifiers>
        <balance>1228.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2873.52000000</valUSD>
        <pctVal>0.014117976437</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Rallybio Corp.</name>
        <lei>N/A</lei>
        <title>Rallybio Corp.</title>
        <cusip>75120L100</cusip>
        <identifiers>
          <isin value="US75120L1008"/>
        </identifiers>
        <balance>669.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7392.45000000</valUSD>
        <pctVal>0.036320065603</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Aclaris Therapeutics, Inc.</name>
        <lei>5493000B2LQ9QTW1DF52</lei>
        <title>Aclaris Therapeutics, Inc.</title>
        <cusip>00461U105</cusip>
        <identifiers>
          <isin value="US00461U1051"/>
        </identifiers>
        <balance>1397.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>22226.27000000</valUSD>
        <pctVal>0.109200547116</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Solid Biosciences Inc.</name>
        <lei>N/A</lei>
        <title>Solid Biosciences Inc.</title>
        <cusip>83422E105</cusip>
        <identifiers>
          <isin value="US83422E1055"/>
        </identifiers>
        <balance>2388.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1528.32000000</valUSD>
        <pctVal>0.007508834373</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Inovio Pharmaceuticals, Inc.</name>
        <lei>529900B9W875XDZXTM97</lei>
        <title>Inovio Pharmaceuticals, Inc.</title>
        <cusip>45773H201</cusip>
        <identifiers>
          <isin value="US45773H2013"/>
        </identifiers>
        <balance>4767.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>10916.43000000</valUSD>
        <pctVal>0.053633836381</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>IVERIC bio, Inc.</name>
        <lei>549300GZXI59U71XPM70</lei>
        <title>IVERIC bio, Inc.</title>
        <cusip>46583P102</cusip>
        <identifiers>
          <isin value="US46583P1021"/>
        </identifiers>
        <balance>2439.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>23999.76000000</valUSD>
        <pctVal>0.117913933496</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="24115.86000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Tricida, Inc.</name>
        <lei>549300QVPFFJC8SZXG25</lei>
        <title>Tricida, Inc.</title>
        <cusip>89610F101</cusip>
        <identifiers>
          <isin value="US89610F1012"/>
        </identifiers>
        <balance>1160.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14523.20000000</valUSD>
        <pctVal>0.071354365167</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3999.21000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Compass Pathways Ltd.</name>
        <lei>213800N7CUZIC6QSTZ31</lei>
        <title>Compass Pathways Ltd., ADR</title>
        <cusip>20451W101</cusip>
        <identifiers>
          <isin value="US20451W1018"/>
        </identifiers>
        <balance>489.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7990.26000000</valUSD>
        <pctVal>0.039257183666</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="7222.80000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Instil Bio, Inc.</name>
        <lei>N/A</lei>
        <title>Instil Bio, Inc.</title>
        <cusip>45783C101</cusip>
        <identifiers>
          <isin value="US45783C1018"/>
        </identifiers>
        <balance>2702.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14050.40000000</valUSD>
        <pctVal>0.069031437447</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Oyster Point Pharma, Inc.</name>
        <lei>N/A</lei>
        <title>Oyster Point Pharma, Inc.</title>
        <cusip>69242L106</cusip>
        <identifiers>
          <isin value="US69242L1061"/>
        </identifiers>
        <balance>562.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3512.50000000</valUSD>
        <pctVal>0.017257368049</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3419.40000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Aeglea BioTherapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Aeglea BioTherapeutics, Inc.</title>
        <cusip>00773J103</cusip>
        <identifiers>
          <isin value="US00773J1034"/>
        </identifiers>
        <balance>1283.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>671.01000000</valUSD>
        <pctVal>0.003296759155</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Moderna, Inc.</name>
        <lei>549300EI6OKH5K5Q2G38</lei>
        <title>Moderna, Inc.</title>
        <cusip>60770K107</cusip>
        <identifiers>
          <isin value="US60770K1079"/>
        </identifiers>
        <balance>8319.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1100354.13000000</valUSD>
        <pctVal>5.406182549653</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Akebia Therapeutics, Inc.</name>
        <lei>549300CBQEHMKEEGNX42</lei>
        <title>Akebia Therapeutics, Inc.</title>
        <cusip>00972D105</cusip>
        <identifiers>
          <isin value="US00972D1054"/>
        </identifiers>
        <balance>3814.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1389.44000000</valUSD>
        <pctVal>0.006826498921</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Tenaya Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Tenaya Therapeutics, Inc.</title>
        <cusip>87990A106</cusip>
        <identifiers>
          <isin value="US87990A1060"/>
        </identifiers>
        <balance>868.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3810.52000000</valUSD>
        <pctVal>0.018721578960</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alkermes PLC</name>
        <lei>549300YHRMYLL071E243</lei>
        <title>Alkermes PLC</title>
        <cusip>G01767105</cusip>
        <identifiers>
          <isin value="IE00B56GVS15"/>
        </identifiers>
        <balance>3432.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>81235.44000000</valUSD>
        <pctVal>0.399120252442</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Veracyte, Inc.</name>
        <lei>529900ESWZRHXOW27Z37</lei>
        <title>Veracyte, Inc.</title>
        <cusip>92337F107</cusip>
        <identifiers>
          <isin value="US92337F1075"/>
        </identifiers>
        <balance>1498.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>30559.20000000</valUSD>
        <pctVal>0.150141312934</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="24332.13000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Gritstone bio, Inc.</name>
        <lei>5493003TER6KY3MUVY84</lei>
        <title>Gritstone bio, Inc.</title>
        <cusip>39868T105</cusip>
        <identifiers>
          <isin value="US39868T1051"/>
        </identifiers>
        <balance>1496.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4921.84000000</valUSD>
        <pctVal>0.024181638251</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Mustang Bio, Inc.</name>
        <lei>5493004W0VC1DPECQ779</lei>
        <title>Mustang Bio, Inc.</title>
        <cusip>62818Q104</cusip>
        <identifiers>
          <isin value="US62818Q1040"/>
        </identifiers>
        <balance>2165.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1315.24000000</valUSD>
        <pctVal>0.006461944698</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PetIQ, Inc.</name>
        <lei>549300GROACFGKVYOX14</lei>
        <title>PetIQ, Inc.</title>
        <cusip>71639T106</cusip>
        <identifiers>
          <isin value="US71639T1060"/>
        </identifiers>
        <balance>610.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5697.40000000</valUSD>
        <pctVal>0.027992065116</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Anavex Life Sciences Corp.</name>
        <lei>549300K1I5L8COCQ8W36</lei>
        <title>Anavex Life Sciences Corp.</title>
        <cusip>032797300</cusip>
        <identifiers>
          <isin value="US0327973006"/>
        </identifiers>
        <balance>1627.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>15602.93000000</valUSD>
        <pctVal>0.076659218691</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="15343.30000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Terns Pharmaceuticals, Inc.</name>
        <lei>254900S1ZDQMF4MYP709</lei>
        <title>Terns Pharmaceuticals, Inc.</title>
        <cusip>880881107</cusip>
        <identifiers>
          <isin value="US8808811074"/>
        </identifiers>
        <balance>530.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2067.00000000</valUSD>
        <pctVal>0.010155439076</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SAB Biotherapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>SAB Biotherapeutics, Inc.</title>
        <cusip>78397T103</cusip>
        <identifiers>
          <isin value="US78397T1034"/>
        </identifiers>
        <balance>872.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>610.49000000</valUSD>
        <pctVal>0.002999416546</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Mereo BioPharma Group PLC</name>
        <lei>213800U8JQHIJOS5AS09</lei>
        <title>Mereo BioPharma Group PLC, ADR</title>
        <cusip>589492107</cusip>
        <identifiers>
          <isin value="US5894921072"/>
        </identifiers>
        <balance>2441.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2929.20000000</valUSD>
        <pctVal>0.014391539498</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Verve Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Verve Therapeutics, Inc.</title>
        <cusip>92539P101</cusip>
        <identifiers>
          <isin value="US92539P1012"/>
        </identifiers>
        <balance>1260.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>48333.60000000</valUSD>
        <pctVal>0.237469245361</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="47373.53000000"/>
        </securityLending>
      </invstOrSec>
    </invstOrSecs>
    <signature>
      <ncom:dateSigned>2022-09-30</ncom:dateSigned>
      <ncom:nameOfApplicant>Invesco Exchange-Traded Fund Trust II</ncom:nameOfApplicant>
      <ncom:signature>Sheri Morris</ncom:signature>
      <ncom:signerName>Sheri Morris</ncom:signerName>
      <ncom:title>Vice President</ncom:title>
    </signature>
  </formData>
</edgarSubmission>
